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ABSTRACT
Despite its extensive use as a prokaryotic bioreporter, only recently has the
bacterial bioluminescence (lux) system been adapted to express at a functional
level in the mammalian cellular background. While this novel strategy has the
potential to contribute to the fields of high throughput screening and non-invasive
in vivo imaging due to its autonomous substrate production, it is still constrained
because its signal intensity is lower than that of other bioluminescent reporters.
This work demonstrates the development of strategies that optimize human cell
lux-based bioluminescence to overcome this detriment for advancement towards
a fully functional lux reporter system. To enhance lux gene expression, a single
vector construct has been developed that improves upon the initial two plasmid
expression system. This construct separates the lux genes using viral-derived 2A
elements, allowing for simultaneous expression of the six genes from a single
promoter in eukaryotic cells. This strategy results in increased bioluminescent
output compared to the previous two plasmid system. Additionally, it is
demonstrated that gene copy number is the primary limiting factor for
bioluminescent output following expression in human cell lines. This limitation
has been overcome through the development of a two-step transfection strategy
that yields significantly higher transfection efficiency and improves both
transgene integration and bioluminescence output. An optimized HEK293 cell
line with enhanced bioluminescent production has been constructed using the
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two-step

transfection

strategy.

The

enhanced

signal

intensity

allows

bioluminescent detection from a smaller population size in cell culture compared
to their un-optimized counterparts, as well as detection using alternative lower
cost instruments. A developmental effort towards lux-based biosensing in human
cell lines is also reported in this study. It has been shown that bioluminescence
emitted constitutively from lux-expressing human cell lines can be utilized for
monitoring population dynamics in a non-invasive manner and that, by regulating
the expression of the lux genes, the lux system can function as a fully
autonomous bioreporter for continuous monitoring of targets of interest.
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CHAPTER I
Introduction
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Background and Research Objectives
Mammalian cells expressing reporter proteins that are capable of producing
an optical signal are progressively becoming more widely employed by
investigators from diverse backgrounds to interrogate a variety of cellular
functions in cell culture and living animals (Baker 2010). These applications
include, but are not limited to, tumorigenesis and cancer treatment (Rehemtulla,
Stegman et al. 2000; Venisnik, Olafsen et al. 2006), gene expression and
regulation (Rettig, McAnuff et al. 2006; Korpal, Yan et al. 2009), cell trafficking
(Sheikh, Lin et al. 2007; van der Bogt, Sheikh et al. 2008), viral and pathogenic
infection (Andreu, Zelmer et al. 2011), protein stability and function (Laxman, Hall
et al. 2002; Wang, Fu et al. 2010), and protein-protein interactions (Paulmurugan,
Umezawa et al. 2002; Pichler, Prior et al. 2008). Currently, the mainstays of
optical reporter proteins used for these applications are fluorescent proteins
(GFP and its other color variants) and bioluminescent proteins (luciferase
enzymes) isolated from insects and marine organisms. The optical signal
generated by these proteins allows for visualization of the cellular events of
interest, but each type of these reporters is associated with its own
disadvantages. Fluorescent proteins, for instance, require an initial excitation for
light emission. It is this excitation that can produce high levels of background
fluorescence from endogenous biological structures in cultured cells and whole
animal imaging, thus greatly reducing the sensitivity and resolution of this
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technique and interfering with data interpretation.
With little to no endogenous bioluminescent activity in mammalian cells and
tissues, the use of luciferase proteins has the advantage over their fluorescent
counterparts of near background-free detection, especially for in vivo whole
animal imaging. However, most of the currently available luciferase proteins
require addition of an exogenous substrate for bioluminescent emission. In cell
culture based applications, the substrate addition is often associated with cell
lysis, therefore only providing measurements on a single time point basis. For in
vivo whole animal imaging, the required substrate is usually injected directly
without animal sacrifice. Although this allows for repeated monitoring of a single
subject, due to rapid substrate uptake and consumption (Bhaumik and Gambhir
2002; Inoue, Kiryu et al. 2009), detection using these luciferase proteins has
relatively short temporal dynamics, and is thus handicapped for long term
monitoring applications.
The only substrate-free bioluminescent reporter system that has been
developed to date is the bacterial bioluminescence (lux) system. Setting it apart
from other luciferase systems is that it is capable of generating its own substrate,
therefore eliminating the need for cell destruction or substrate addition for signal
detection. Due to this unique feature, the lux system is highly amenable towards
continuous on-line biosensing. Indeed, it is extensively used as a prokaryotic
bioreporter for environmental assessment (Shin 2011; Singh, Abhilash et al.
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2011) and pathogenic infection (Contag, Contag et al. 1995; Francis, Joh et al.
2000; Trcek, Berschl et al. 2010). The advantage offered by the lux system over
other substrate-requiring luciferase systems has made it an attractive target for
development into a mammalian reporter, but it is not until very recently that it has
been adapted to express at a functional level for autonomous bioluminescent
production in mammalian cells (Close, Patterson et al. 2010). While this initial
demonstration opens the door for continuous real-time monitoring of cellular
processes in mammalian cells and in living animals, the current mammalianadapted lux system is not capable of producing levels of bioluminescent signal as
high as any of the other substrate-requiring luciferase systems, which is the
major limitation for more widespread applications. To address this issue, this
work has been focused on the optimization of lux-based bioluminescent
expression and its development as an autonomously bioluminescent reporter in
human cell lines. The investigations presented in this dissertation have been
performed under the following experimental hypotheses:
Hypothesis 1: Through the use of viral 2A peptides as linker regions, it will
be possible to simultaneously express up to six genes (the luxCDABEfrp gene
cassette) under the regulation of

a single promoter for autonomous

bioluminescent production in human cell lines.
Hypothesis 2: The human cellular background is capable of supplying
sufficient endogenous substrates for high level lux-based bioluminescent
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production. Therefore, it will be possible to improve bioluminescent expression
through increased gene integration.
Hypothesis 3: Bioluminescent production dynamics in estrogen-responsive
human breast carcinoma T-47D cells can be used as an indicator for estrogenregulated cell proliferation.
Hypothesis 4: By simultaneously regulating the expression of the lux genes
assembled in a polycistronic single vector, it will be possible to construct a
bioluminescent reporter capable of responding to target analyte autonomously
and in a near real-time manner.

Literature Review
What is bacterial bioluminescence?
Bioluminescence – the chemical generation of light within a living organism –
is widely distributed in nature. Displayed by over 700 genera, bioluminescence
can be found in both terrestrial and aquatic environments. On land it is most
commonly observed in the glow of fungi growing on decaying wood or from
insects displaying their luminescent signal after dusk, while in marine
environments bioluminescence is most commonly observed in bacteria that are
found either living freely or in symbiosis with larger hosts. It is these
bioluminescent bacteria that are the most abundant and widely distributed of the
light emitting organisms on Earth. Despite the widespread prevalence of bacterial
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bioluminescence, however, the majority of these organisms are classified into
just three genera: Vibrio, Photobacterium, and Photorhabdus (Xenorhabdus)
(Meighen 1991).

Although they are viable as free-living bacterium, these

organisms are most commonly observed in symbiosis with a larger host. There is
still no consensus as to the evolutionary benefit of bioluminescent production,
however, in general it is theorized that the production of light can aid in the
consumption of free living bacteria by higher trophic organisms, transferring them
to a more controlled, nutrient rich habitat inside the host, or that, likewise,
symbiotic bacteria can aid their hosts through the production of light that attracts
prey, aids in camouflage, or attracts mates, in return for the shelter and nutrients
provided by living within the body of the host organism (Nealson and Hastings
1979).
The genetic system employed for the generation of bioluminescence is well
conserved across all known bioluminescent bacteria. Five genes, usually
organized in an operon as luxCDABE, are essential for bioluminescence
production. The luciferase protein catalyzing the bioluminescent reaction is a
heterodimer formed by the luxA and luxB gene products. The long-chain fatty
aldehyde substrate required for light emission is produced by a protein complex
encoded by the luxC, luxD, and luxE genes. Specifically, the luxD gene encodes
a transferase that converts intracellular myristyl-ACP, an intermediate for
membrane synthesis, to myristic acid, which is further converted to myristyl
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aldehyde by the reductase/synthase protein complex encoded by the luxC and
luxE genes. In some species, there is an additional gene, frp, which functions as
a flavin reductase to aid in the regeneration of the required FMNH2 substrate.
Together with molecular oxygen, these components are all that are required to
produce a bioluminescent signal (Meighen 1991) (Figure 1). The overall reaction
can be summarized as the following:
FMNH2 + RCHO + O2 →FMN + H2O + RCOOH + hν490nm
The history of using bacterial bioluminescence as a prokaryotic bioreporter
First examples of transgenic lux expression
Even before the mechanisms responsible for bioluminescence were
completely explored in the organisms that naturally expressed it, the lux system
had gained attention in regards to its potential as a reporter because of the facile
detection and quantification of visible light produced by the Lux proteins. Work
therefore quickly began to introduce the lux genes into non-luminescent bacterial
species to determine if the modified organisms could acquire the light-emitting
phenotype. These initial attempts to isolate and exogenously express the lux
genes in non-native hosts such as E. coli were driven primarily by the desire to
understand the organization, regulation, and function of the genetic components
responsible for bioluminescence. The first major advancement in these
investigations occurred in 1982 when Belas et al. (1982) demonstrated
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Figure 1. Bacterial bioluminescence reaction.
The luciferase that catalyzes the bioluminescent reaction is a heterodimer
formed from the luxA and luxB gene products. The luxC, luxD, and luxE
gene products work synergistically to synthesize and regenerate the
myristoyl aldehyde co-substrate for the reaction. The frp gene encodes a
flavin reductase that has been found to facilitate FMNH2 recycling in
eukaryotic cells. Used with permission from (Close, Ripp et al. 2009).
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bioluminescent production from recombinant Escherichia coli containing the
Vibrio harveyi luxA and luxB genes upon addition of exogenous aldehyde. In less
than one year following this successful demonstration, the entire lux cassette
(luxCDABE), together with its associated regulatory genes, was isolated from V.
fischeri (more recently designated as Aliivibrio fischeri) and introduced into E. coli
(Engebrecht, Nealson et al. 1983), resulting in the first recombinant strain
capable of emitting light without aldehyde supplementation. This process was
soon repeated using the Photorhabdus luminescens genes, suggesting the
universal nature of the operon (Frackman, Anhalt et al. 1990; Fernandezpinas
and Wolk 1994). Although these efforts focused primarily at interrogating the
functions of the individual lux genes, investigators began to appreciate the
sensitivity, ease of detection, and non-destructive features the lux system offered
as

a

bioluminescent

reporter.

The

practical

nonexistence

of

in

vivo

bioluminescence from bacteria not expressing the lux genes provides a high
signal-to-noise ratio for the recombinant lux reporter system and the fast turnover
rate of the bacterial luciferase enzyme allows for rapid light production. Taken
together, these attributes have allowed the development of bacterial bioreporters
that can be continuously monitored in a near real-time fashion. In addition,
because the resulting bioluminescence is emitted in an autonomous manner,
these reporters can be employed in a high throughput manner with very low cost,
making them attractive options for a large number of biomonitoring applications.
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Development of lux as a method for visualizing gene expression
The first use of lux as a biomonitoring technology came soon after its
transgenic expression in E. coli, when Engebrecht et al. (1985) fused the lux
cassette to an inducible promoter that could be used to monitor gene expression
in vivo. Using this experimental design it became possible to monitor
autonomous bioluminescence as an indicator for transcriptional activity of a
promoter of interest. Using this method, the first major targets of study were the
E. coli lac and ara promoters and it was discovered that upon IPTG or arabinose
induction, light production in hosts expressing lux fusions increased between 600
to 1000-fold. Following these reports, the lux system was used to monitor
regulation of the lateral flagella genes in Vibrio parahaemolyticus (Engebrecht,
Simon et al. 1985; Belas, Simon et al. 1986), providing its first demonstration in a
previously uncharacterized system. These applications represented a significant
shift in the way gene expression was investigated because, unlike traditional
biochemical assays using enzymatic reporters, the bioluminescent signal from
the lux genes could be easily detected and measured with high sensitivity without
cell perturbation. This allowed the same sample to be continuously monitored,
thus revealing the dynamics of gene expression through changes in
bioluminescence over time.
lux-based bioluminescence as a tool for cellular population monitoring
While the Lux proteins do not require exogenous substrate addition, their
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function does require continued access to their molecular oxygen, FMNH2, and
aldehyde co-substrates. For this reason, their bioluminescence can only be
detected in actively growing cells. This knowledge, combined with the discovery
that lux bioluminescent output is proportionally correlated to the number of cells
present, has therefore been used as a simple, sensitive, and non-destructive
means for in situ bacterial monitoring. This was first demonstrated by Shaw et al.
(Shaw and Kado 1986) in 1986 when constitutively expressed V. fischeri
luxCDABE genes were introduced into the phytopathogen Xanthomonas
campestris, and their subsequent invasion of a cauliflower leaf was visualized.
Similarly, de Weger and colleagues (de Weger, Dunbar et al. 1991) were
successfully able to detect luxCDABE-labeled Pseudomonas fluorescens in the
rhizosphere of soybean roots using the same technique. Additionally, through the
use of a lux-based system rather than an enzymatic reporter, it was possible for
these researchers to achieve detection limits three orders of magnitude lower
than what was previously possible, leading to improved signal detection. These
early examples highlighted the application of lux-based bioluminescence as a
rapid, simple and sensitive tool for in situ detection of living bacteria and
established the foundation for future research using lux to monitor genetically
engineered microorganisms. In perhaps the most notable use of the lux genes for
tracking a cellular population, a P. fluorescens strain was transformed with the
lux genes and used for the first bioremediation-related environmental field
release of a genetically engineered microorganism in 1996 (Ripp, Nivens et al.
11

2000). By placing the lux genes under the control of promoters in the
naphthalene

degradation

pathway,

it

was

possible

to

monitor

their

bioluminescent output as a measure of naphthalene contamination in the soil
(King, Digrazia et al. 1990). Using a combination of bioluminescent and
traditional culture based detection methods, the release area was monitored for
two years after the release of bioluminescent P. fluorescens. Over this time,
regular sampling was performed to track the amount of bacteria present in the
soil, as well as the amount of bioluminescence produced, which were indicative
of organism presence and naphthalene degradation, respectively. Based on
culture detection methods, the bioluminescent P. fluorescens persisted in both
contaminated and non-contaminated soils, decaying at similar rates and
producing similar colony counts (Ripp, Nivens et al. 2000). The long term nature
and difficulty in remote monitoring of bacterial populations presented in this study
illustrates how the unique properties of the lux operon can provide it with an
advantage over its substrate requiring bioluminescent or UV stimulation requiring
fluorescent counterparts. Because of its autonomous nature, the lux-tagged P.
fluorescens could be continually surveyed for bioluminescent production without
the need for repeated stimulation to induce a reporter signal.
The use of lux for exogenous target detection
Following the work that demonstrated how the lux cassette could be used as
a tool for visualizing gene expression, it soon became clear that these genes
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could be adapted for use as a traditional bioreporter target through activation
under specific, predetermined conditions as well. By expressing the lux cassette
under the control of a promoter with a known inducer, the resultant
bioluminescent emission could be used as an indicator for the presence of the
given stimulus, and fluctuation of the bioluminescent signal could be interpreted
as changes in the bioavailable concentration of the inducer compound. Building
upon these ideas, the first use of bioluminescence for monitoring metabolic
activity was demonstrated in Pseudomonas putida by Burlage et al. in 1990
(Burlage, Sayler et al. 1990). Here, naphthalene degradation was monitored
using a transcriptional fusion of the salicylate inducible nah promoter and the
luxCDABE genes. Salicylate is an intermediate metabolite of naphthalene, which
is eventually degraded to acetaldehyde and pyruvate in Pseudomonas.
Therefore, naphthalene degradation could be correlated to light emission upon
induction with naphthalene-derived salicylate. The nondestructive nature of the
lux system allowed for this analysis to occur in real time in a growing culture,
providing continuous monitoring of naphthalene metabolism across various
stages of growth. It was later determined by King et al. (King, Digrazia et al. 1990)
that the bioluminescent signal was controlled in a dose/response fashion,
therefore demonstrating its usefulness in determining contaminant levels in
mixed environmental samples. This opened the door for a multitude of
environmental bioreporters featuring lux, such as that developed by Applegate
and colleagues that was used to monitor for water soluble benzene, toluene,
13

ethylbenzene, and xylene (BTEX) compounds indicative of petroleum spills. This
reporter, constructed by linking expression of the lux cassette to the toluene
dioxygenase promoter, was capable of detecting as little as of 30 µg of toluene /
L in as quickly as 2 hours and maintained its detection ability for over 100
generations without antibiotic selection (Applegate, Kehrmeyer et al. 1998).
Another common target for lux-based environmental sensing has been phenol.
Notably, Abd-El-Haleem et al. (Abd-El-Haleem, Ripp et al. 2002) constructed one
of the first lux-based phenol biosensors by inserting a mopR-like promoter fused
to the V. fischeri lux cassette genes into Acinetobacter sp DF4. This reporter was
capable of demonstrating a lower detection limit of 2.5 ppm in 4 hours when
exposed to phenol, and was only responsive to three of the ten phenol
derivatives tested, suggesting that is was relatively specific. This is, however, not
by any means the only lux-based phenol reporter to be developed. Davidov et al.
(Davidov, Rozen et al. 2000) made extensive use of recA promoters fused to lux
cassettes, with each of the reporters containing a slight variation in its promoter
sequence, that were expressed either in E. coli or Salmonella typhimurium and
using lux genes from either V. fischeri or P. luminescens. The most sensitive of
these reporters was that expressing the V. fischeri lux genes in E. coli, which was
capable of detecting 0.008 mg phenol / L in 2 hours. This same construct, when
expressed in S. typhimurium was also capable of detecting phenol in 2 hours but
required a minimum concentration of 16 mg phenol / L, demonstrating the
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differences in host phenol bioavailability.
Concerns of exogenous gene expression in a surrogate host
Although nucleic acids serve as the universal genetic material and the central
dogma applies to all organisms, exogenous expression of foreign genes is not as
straightforward as delivering the target sequence into host cells and waiting for it
to be expressed. This is because the gene expression machinery in certain
species has evolved in such a way as to manipulate its own genetic material
more efficiently than genomic material from other species, a fact that is especially
true when the exogenous genetic material is from a very distantly related species.
For example, the prokaryotic and eukaryotic cells differ in the basic components
for processing genetic information (Table 1). Any discrepancies, such as the
genomic characteristics of GC content and codon usage patterns between the
native and surrogate hosts will play an important role in the efficiency of
exogenous gene expression. In addition, some organisms have also evolved to
recognize and remove or silence foreign genetic sequences in order to protect
themselves from the deleterious effects of foreign DNA expression. It is only
through mimicking, circumventing, or deactivating these mechanisms that it
becomes possible to efficiently express a foreign gene in a surrogate host.
Therefore, by understanding how these mechanisms work, it increases the
likelihood that a strategy can be developed for effective exogenous gene
expression.
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Table 1. Comparison of gene expression in prokaryotic and eukaryotic cells.
Gene expression

Prokaryotes

Eukaryotes

Location

Occurs in cytoplasm

Occurs in nucleus

Enzymes

Single polymerase

Pol I, Pol II, and Pol III

Transcription initiation

-10, -35, and UP
recognition elements

TATA box and TRIIB recognition
elements

Coding region

Single coding region

Multiple coding regions with exons
and introns

mRNA processing

Rho dependent and
independent termination

5' capping, splicing, and 3'
polyadenylation

Modified from (Close, Xu et al. 2012).
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GC content
The term GC content refers to the percentage of guanine and cytosine bases
in a DNA sequence. It can be used to describe a gene, a chromosome, a
genome, or even any region of a particular DNA sequence. Different organisms
can vary significantly in their genomic GC content. For example, Plasmodium
falciparum has an extremely GC-poor genome, with a GC content of
approximately 20%, while Streptomyces coelicolor possess a GC content as high
as 72%.
Due to the difference in thermodynamic stability between the GC bonding
pairs and the AT bonding pairs, GC content can affect the formation and stability
of both DNA and RNA secondary structures, which are important factors in the
regulation of gene expression (Kubo and Imanaka 1989; Kudla, Murray et al.
2009). In bacteria, the Shine-Dalgarno ribosome binding site that is located in the
5’ untranslated region of the mRNA is relatively AU-rich. The presence of this
high AT abundance and low secondary structure stability at the 5’ end of a
coding region has been found to contribute significantly to producing high
translation efficiency in bacteria (Desmit and Vanduin 1990; Allert, Cox et al.
2010). Furthermore, Kudla et al. have demonstrated that the addition of these
types of AU-rich leader sequences to the 5’ untranslated region of genes can
improve the expression levels of otherwise poorly expressed proteins (Kudla,
Murray et al. 2009). In a recent systematic study of 340 genomes from various
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groups of organisms including bacteria, archaea, fungi, plants, insects, fishes,
birds, and mammals, Gu and colleagues discovered a trend of reduced mRNA
stability near the start codon in most organisms except birds and mammals and
that this reduction results in changes in mRNA stability that are correlated with
genomic GC content (Gu, Zhou et al. 2010).
In birds and mammals, however, the genome-wide trend of reduced mRNA
stability near the translation initiation site has not been observed, even though
the GC content in these organisms is not significantly different from the species
where such a trend was originally observed (Gu, Zhou et al. 2010). The authors
speculate that this difference is due to the isochore-type structure in the
genomes of these organisms. An isochore is the result of a high variation in GC
content over large-scale sequences within a genome (Bernardi 1995). Within an
isochore structure, however, the GC content is generally homogeneous
regardless of the heterogeneous nature of the remainder of the genome (EyreWalker and Hurst 2001). It is important to note that, unlike in E. coli, high GC
content within the coding region usually increases expression in mammalian cells
(Kudla, Lipinski et al. 2006). Kudla and colleagues have found that GC-rich
genes in mammalian cells were transcribed more efficiently than alternate, GCpoor versions of the same gene, leading to higher protein production. In fact, the
5’ cap and Kozak consensus sequence located on the 5’ untranslated region
normally have a GC-rich composition in eukaryotic genes (Kozak 1987).
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It is widely accepted that genomic GC content has co-evolved with the gene
expression machinery to ensure optimal expression for the fitness of the host
(Andersson and Kurland 1990; Kudla, Murray et al. 2009). Therefore, with
regards to expression of exogenous genes, the difference in the GC contents
between the target genes, especially at the 5’ end, and the expression host can
also impact the expression level of foreign genes. The difficulty in expressing
Plasmodium falciparum genes in E. coli is hypothesized to be attributed to its
extreme low GC content and the possibility of degradation of mRNA by
ribonuclease E (McDowall, Linchao et al. 1994; Plotkin and Kudla 2011). Plotkin
and Kudla also predicted that more than 40% of human genes would be
expressed poorly in E. coli without modification due to the relatively high GC
content at the 5’ end of mRNA and subsequent low 5’ folding energy (Plotkin and
Kudla 2011).
Codon usage bias
In addition to determining mRNA stability and secondary structure
organization, another feature of every genome that is impacted by GC content is
its codon usage profile. The 20 amino acids commonly found in protein
sequences are all encoded from a series of 61 different nucleotide triplets. The
redundancy of this coding system necessarily allows the same amino acid to be
encoded by several different codons. For example, the amino acids alanine and
serine can be encoded using either four or six codons, respectively. This innate
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degeneracy that is built into the genetic code has evolved to play a role in
protecting DNA sequences from otherwise deleterious mutations by preserving
their resultant protein sequences despite the inevitable incorporation of mutations
at the genetic level, effectively silencing these mutations. However, the available
synonymous codons are not used at equal frequencies across all species, nor
across different regions within the same genome, and sometimes not even within
the same gene (Andersson and Kurland 1990; Kurland 1991). Predictably, the
discrepancy of codon usage profiles is greatest between remotely related
species, while more closely related species are more likely to share similar codon
preferences. Although the mechanistic processes underlying how an organism
develops a specific codon bias has not been completely resolved (Chamary,
Parmley et al. 2006; Hershberg and Petrov 2008), the GC content of the
preferred codon chosen is thought to be the single most important factor
determining codon usage biases across genomes (Plotkin and Kudla 2011).
Although it was initially believed that synonymous codon substitutions were
simply examples of fortuitous silent mutations, more recent research has
revealed that codon usage patterns can directly affect important cellular
processes such as the efficiency of transcription and translation, the accuracy of
protein translation and even the process of protein folding (Zhang, Hubalewska
et al. 2009; Angov 2011). It is therefore conceivable that the specific codon
usage pattern of an organism has co-evolved along with other cellular machinery
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in order to provide for optimal gene expression and protein function of the host
genes within their natural environment (Grantham, Gautier et al. 1981). In
prokaryotes, for example, the frequency of a codon being used correlates
positively with the intracellular abundance of its corresponding tRNA (Bulmer
1987; Dong, Nilsson et al. 1996). It therefore follows that the expression of nonnative genes is hampered by the existence of variation in their respective codon
usage pattern compared to the host organism. This hypothesis has been
supported throughout the long history of exogenous gene expression, revealing
that the same DNA sequence is often expressed at different efficiencies in
different organisms (Gustafsson, Govindarajan et al. 2004). This is due to the
foreign DNA sequence containing codons that are rarely used in the host. A
situation that leads to low level translational efficiency and low level protein
expression (Kane 1995; Kim and Lee 2006; Rosano and Ceccarelli 2009) due to
a reduced translation elongation rate caused by the imbalance between the
codons used in the target gene sequence and the available pool of charged
tRNA in the host. These expression problems are then compounded by any
incompatibility between the host translation machinery and the mRNA secondary
structure due to changes in GC content from alternate codon usage patterns (Wu,
Jornvall et al. 2004; Kim and Lee 2006).
To overcome these problems, a common strategy aimed at enhancing the
expression of non-native genes in a surrogate host is that of codon optimization.
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This process encompasses the replacement of rare codons within the DNA
sequence in order to closely match the host codon usage bias while retaining
100% identity to the original amino acid sequence. This process of codon
optimization also allows for the simultaneous modification of predicted mRNA
secondary structures that could result from changes in the GC content. This
process is especially helpful in eliminating structures at the 5’ end of coding
regions, where they have an increased likelihood of interfering with downstream
protein expression (Wu, Jornvall et al. 2004). Cis-acting negative regulatory
elements within the coding sequence are also eliminated in order to reduce the
chance of repression, therefore improving expression (Graf, Bojak et al. 2000).
The codon optimization process can be achieved experimentally either through
multiple stages of site-directed mutagenesis on directly cloned DNA, or by
resynthesis of the target gene de novo. The former method may be preferred if
there are a limited number of codons that must be changed, however, latter
method has become more and more practical due to improvements in the gene
synthesis process that have both reduced the cost and time required to generate
synthetic DNA sequences. In general, the codon optimization process has been
shown to increase expression of a typical mammalian gene five- to fifteen-fold
when expressed in an E. coli host (Gustafsson, Govindarajan et al. 2004;
Burgess-Brown, Sharma et al. 2008). Similarly, expression of prokaryotic genes
in eukaryotic cells can be improved significantly using this method as well
(Zolotukhin, Potter et al. 1996; Zur Megede, Chen et al. 2000; Patterson, Dionisi
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et al. 2005).
Mechanisms for removal and silencing of exogenous genes
For an exogenous gene to be expressed in a non-native host, the foreign
DNA must be physically delivered into the host cell and then properly integrated
into the gene expression and regulation network within the host. Decades of
research in the fields of molecular and cellular biotechnology have provided
many effective techniques for the introduction of genetic material into both
prokaryotic and eukaryotic hosts, however, after the gene has been transferred
into the host cell, it needs to be recognized and processed by the host cell’s
replication, transcription and translation machinery before it can be expressed as
a functional protein. However, because expression of a foreign gene is often
deleterious to host survival under wild type conditions, many organisms have
evolved defense mechanisms that remove or silence foreign DNA in order to
protect themselves from this potentially detrimental process. In bacteria, for
example, the invading foreign DNA can be cleaved by restriction endonucleases
that recognize specific, non-self, nucleotide sequences, in a phenomenon
referred to as restriction. In this process the native genetic material is often
methylated at certain positions by methylase enzymes, therefore preventing
recognition and degradation by the restriction endonucleases, and ensuring the
maintenance and expression of native DNA sequences. This restriction
modification system was first discovered in the 1960s and since that time has
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been demonstrated to be common in many bacterial species (Wilson and Murray
1991). The restriction system, however, is not the only defense mechanism that
has been developed to protect the host from expression of foreign genetic
material. It has been demonstrated that Gram-negative bacteria are capable of
selectively repressing horizontally acquired genes through their interaction with a
histone-like nucleoid structuring (H-NS) protein. This phenomenon, termed
xenogeneic silencing, was first discovered in 2006 by Navarre, Lucchini, Oshima
and colleagues (Lucchini, Rowley et al. 2006; Navarre, Porwollik et al. 2006;
Oshima, Ishikawa et al. 2006). The H-NS protein responsible for xenogeneic
silencing belongs to a family of nucleoid-associated proteins that bind to AT-rich
DNA sequences with low sequence specificity. In the case of xenogeneic
silencing, H-NS protein targets the laterally acquired sequence because it
exhibits a lower GC content than the host genome, allowing it to selectively
repress the expression of exogenous DNA.
Unlike the prokaryotic approaches for silencing of exogenous DNA
sequences, no mechanism for the direct removal of foreign genetic material has
yet been proposed to function in eukaryotic organisms. Nonetheless, the
expression of exogenous DNA in plants and mammalian cells often suffers from
low efficiency due to epigenetic modification. These modifications lead to
unstable expression and, in extreme cases, silencing of the transgene over time.
Silencing can occur at either the transcriptional or post-transcriptional level
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through changes in the methylation status of the sequence, histone modification,
or RNA interference (Pikaart, Recillas-Targa et al. 1998; Pal-Bhadra, Bhadra et
al. 2002; Riu, Chen et al. 2007). Regardless of the protective measures taken,
these mechanisms are all employed by the host to regulate expression of
exogenous genes and protect it from deleterious effects. One final concern that
cannot yet be controlled for is that, due to the random integration following
chromosomal introduction of an exogenous gene into the host chromosome,
expression of the transgene can be highly dependent on the site of insertion.
Depending on the location of integration, various position effects and epigenetic
events often result in high variation of the expression level between individual
expression attempts. While there is no way to reliably control for genomic
insertion position of exogenous genes in the majority of cases, several elements
have been proposed that can help to counteract the resultant position effects and
achieve sustained transgene expression.
Regulatory sequences that must be considered for optimal exogenous
gene expression
By developing a comprehensive understanding of the mechanisms underlying
gene expression and appreciating how factors such as GC content and codon
usage bias influence protein expression in non-native hosts, investigators can
begin to develop theoretical guidelines for the rational design of DNA sequences
optimally tuned for heterologous expression in their target organism. This
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approach is especially attractive, with the reduced time and cost of gene
synthesis allowing for de novo production of complete genes and even entire
expression cassettes making it possible to simply design a gene sequence and
begin working. However, there are additional concerns that must be addressed
prior to successful expression of an exogenous gene sequence. Besides the
optimization of the coding region, regulatory sequences that are not transcribed
or translated should also be taken into consideration in order to achieve optimal
expression. Although not expressed in the final protein product, these elements
are involved in the transcription, translation and long-term maintenance of target
genes in the surrogate host, making their optimization just as important as
optimization of the coding sequence itself.
Regulatory elements involved in transcription
The process leading from a gene to a functional protein starts with
transcription by RNA polymerase. Therefore transcription initiation is often an
important point of control for exogenous protein expression. The driving force
behind recruiting and binding the polymerase that will transcribe the DNA to
mRNA is the promoter sequence that is required to recruit the host’s transcription
machinery. Even though the promoter itself is not transcribed or translated,
choosing a promoter that can be efficiently processed by the host’s machinery
therefore has a significant impact on the success of the design strategy.
Commonly, strong, constitutive promoters that are normally used to drive the
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expression of endogenous housekeeping genes in the expression host are
chosen for high level expression of exogenous genes. For example, the T7,
alcohol dehydrogenase 1 (ADH1) and human elongation factor 1 α promoters
(EF1-α) are commonly employed for heterologous protein expression in E. coli, S.
cerevisiae and mammalian cells, respectively. Viral promoters such as the
cytomegalovirus immediate early (CMV IE) promoter and the Simian virus 40
(SV40) regulatory sequences are also used to drive transgene expression in
mammalian cells as well. It is important to note, however, that while the strength
of the promoter used can at least partially determine the level of transgene
expression, different promoters can have variable rates of transcription across
different cell lines. For this reason, the selection of an appropriate promoter
should be determined on a case-by-case basis. Recent studies have
systematically compared many of the commonly used promoters in a variety of
cell types (Norrman, Fischer et al. 2010; Qin, Zhang et al. 2010). These types of
references are an excellent source of information when designing constructs with
specific expression needs.
It is also important to remember that promoter sequences can be designed de
novo similar to gene sequences, and that designing a specific primer upstream of
a gene construct may be beneficial if no native alternative promoter sequences
are available. Analysis of a large number of prokaryotic and eukaryotic promoters
has revealed that many promoters contain a conserved core sequence that is
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essential for recognition and binding of RNA polymerase and its cofactors.
Through incorporation of these conserved sequences, it may be possible to
specifically design a promoter sequence, allowing one to tailor expression of their
genetic construct to their specific needs. In prokaryotes, this conserved
sequence is known as the Pribnow box, and consists of a consensus sequence
of six nucleotides, TATAAT (Pribnow 1975). In addition, there is another
conserved element often found 17 bp upstream of the Pribnow box. This
upstream region has a consensus TTGACAT sequence that has been shown to
be crucial for transcription initiation (Rosenberg and Court 1979). In eukaryotic
organisms, the counterpart to the Pribnow box is the TATA box with a consensus
sequence of TATAAA. Besides recruiting the associated transcription machinery,
these core promoter elements are also crucial in defining where RNA synthesis
starts. In prokaryotes, RNA synthesis usually begins 10 bp downstream of the
Pribnow box, whereas the first transcribed nucleotide is located approximately 25
bp downstream of the TATA box in eukaryotes. Therefore in addition to the use
of an appropriate core promoter sequence, the location of that promoter
sequence relative to the coding region should also be carefully considered to
ensure complete transcription of the target genes.
It is important to note that although this minimal core promoter is essential for
transcription, it alone is often not adequate to drive high level protein expression.
In eukaryotes, DNA elements known as enhancers are often employed in tandem
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with the core promoter to enhance gene expression through the recruitment of
additional transcription factors. These enhancers can be found at various
locations, including upstream of the core promoter, within the introns of the gene
driven by the core promoter, and downstream of the genes it regulates as well
(Levine and Tjian 2003). Although the mechanistic function of most enhancers is
still not well understood, some well-studied viral enhancer elements are often
included in common expression vectors as a means to increase the transcription
efficiency of exogenous sequences. For example, the CMV IE enhancer has
been shown to be capable of improving gene expression level by 8- to 67-fold in
lung epithelial cells when combined with several weak promoters (Yew,
Wysokenski et al. 1997) and Li and colleagues have further demonstrated that
adding a SV40 enhancer to the CMV IE enhancer/promoter or 3’ end of the
polyadenylation site can increase exogenous gene expression in mouse muscle
cells by up to 20-fold (Li, MacLaughlin et al. 2001).
Regulatory elements involved in translation
Just as with the requirement of a core promoter sequence for the initiation of
transcription, the presence of certain, conserved sequences at the 5’
untranslated region of mRNA sequences are essential for the initiation of
translation. In prokaryotic organisms, the Shine-Dalgarno sequence on the
transcribed mRNA serves this function by acting as the ribosome binding site
(RBS). This consensus sequence is composed of six nucleotides, AGGAGG,
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which are complementary to the anti-Shine-Dalgarno sequence located at the 3’
end of the 16S rRNA in the ribosome. During the initiation of translation the
ribosome is recruited to the mRNA by this complementary base paring between
the RBS and the 16S rRNA. For this reason, the classic RBS pairing is included
as a standard element in the Registry of Standard Biological Parts
(http://partsregistry.org/). Also included in the registry is a collection of
constitutive prokaryotic RBS containing the Shine-Dalgarno sequence as well as
flanking sequences that are known to affect translation. These sequences are
invaluable when designing promoter and gene sequences, as their incorporation
is required for efficient expression of the synthetic construct.
In eukaryotes, the 40S ribosomal subunit helps to serve this purpose by
attaching to initiation factors that assist in the process of scanning the mRNA,
with the Kozak sequence acting as the main initiator for translation (Kozak 1986;
Kozak 1987). This translational process most commonly begins at the AUG
codon closest to the 5’ end of the mRNA, however, this is not always the case.
Kozak et al. have demonstrated that the distance from the 5’-end, the sequence
surrounding the first AUG codon, and its steric relationship with the 40S
ribosomal subunit all contribute to determining the actual initiation site location.
However, it has been routinely demonstrated that placing the promoter and
Kozak sequence upstream of the initiating codon serves to induce increased
expression of target gene sequences (Morita, Kojima et al. 2000).
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Besides the optimization of the codon usage pattern in the coding region,
additional considerations must be taken into account when expressing
prokaryotic genes in eukaryotic hosts or vice versa. Genes cloned directly from
the genomic library of a eukaryotic organism usually cannot be expressed
successfully in a prokaryotic host due to the presence of intervening, non-coding
regions within the sequence. Unlike eukaryotes, prokaryotes lack the RNA
splicing mechanisms required to remove these intron sequences and produce a
mature mRNA. Therefore, any introns present within the expression construct
must be eliminated prior to introduction into the prokaryotic host.
Elements for simultaneous expression of multiple genes in eukaryotes
Conversely, a significant obstacle towards the expression genomically cloned
bacterial genes in a eukaryotic host is the inability of the host to synthesize
proteins polycistronically from a single mRNA. Unlike in prokaryotes, where
translation of multiple adjacent genes from one promoter is common, translation
in eukaryotic cells normally requires the presence of a methyl-7-G(5’)pppN cap at
the 5’ end of the mRNA prior to recognition by the translation initiation complex at
the start of peptide synthesis (Pestova, Kolupaeva et al. 2001). There are
strategies, however, that allow for co-expression of two or more genes in
eukaryotic cells. On the most basic level, it is possible to express each gene
independently from its own promoter, either through the introduction of multiple
vectors, or introduction of a single vector containing multiple promoters. An
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alternate approach is the expression of the multiple genes using a polycistronic
expression vector that takes advantage of either IRES (Internal Ribosomal Entry
Site) or 2A elements. Derived from a viral linker sequence, the IRES element
allows for 5’-cap-independent ribosomal binding and translation initiation directly
at the start codon of the downstream gene, thus enabling translation of multiple
ORFs from a single mRNA (Jackson 1988; Jang, Krausslich et al. 1988).
Although known IRES sequences vary in length and sequence, certain
secondary structures have been shown to be conserved and important for the
function of the elements (Baird, Turcotte et al. 2006). The most widely used IRES
sequence for expression in mammalian cells is the one derived from
encephalomyocarditis virus (EMCV) (de Felipe 2002). Similar to the IRES
elements, 2A elements are viral sequences that can also be used as a short
linker region to provide translation of two or more genes driven off of a single
promoter. Translation of the 2A element causes an interaction between the newly
synthesized sequence and the exit tunnel of the ribosome. This interaction
causes a “skipping” of the last peptide bond at the C terminus of the 2A
sequence. Despite this missing bond, the ribosome is able to continue translation,
creating a second, independent protein product. To ensure continuous translation,
the stop codon of the ORF upstream of the 2A element must be mutated to avoid
unnecessary termination. By using a combination of various IRES and 2A
elements, investigators have demonstrated polycistronic expression of five genes
simultaneously from a single promoter in mammalian cells (Szymczak and
32

Vignali 2005), illustrating how they can be used to simulate the polycistronic
expression of some bacterial genes.
Elements for sustained maintenance and expression
Integration of exogenous DNA sequences into a host chromosome is usually
required for sustained transgene expression in mammalian cells. Because the
insertion event preceding expression is largely random, the expression level of
the integrated gene can be greatly impacted by the surrounding sequences and
chromatin structure. As a consequence, unstable expression and high variability
between individual clones are the two major issues associated with transgene
expression. In addition, if insertion of the exogenous genes occurs within or in
close vicinity to a required host gene, the health or survivability of the host can be
negatively impacted. To aid in controlling for this type of negative regulation,
several DNA elements capable of preventing these types of position effects and
stabilizing transgene expression have been discovered (Table 2). These DNA
elements are naturally found in mammalian genomes and are crucial for
regulating the proper expression of endogenous genes. The locus control regions
(LCRs) can enhance transcription of linked genes and also enable copy numberdependent gene expression (Li, Peterson et al. 2002), however, their large size
and tissue-specific nature constrain their application in a variety of mammalian
cell types (Kwaks and Otte 2006). Insulators, also known as barriers or
enhancer-blocking elements, are DNA sequences that can protect genes from
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Table 2. DNA elements used to enhance and stabilize transgene expression in
mammalian cells.

Element

Size
(kb)

LCR

16

Insulator
UCOE
MAR

1.22.4
2.58
~3

Increased Stability of
expression expression

Cell
typespecific

Copy
Positionnumberindependent
dependent

Unknown

Yes

Yes

Yes

Unknown

Yes

Unknown No

Majority Yes

Yes

Yes

No

Unknown

Yes

Yes

Yes

No

No

Majority Yes

Yes, if
powerful
enough

0.5Yes
Yes
No
Yes
Yes
2
Originally published in and used with permission from (Close, Xu et al. 2012).
Modified from (Kwaks and Otte 2006) and (Harraghy, Gaussin et al. 2008).
STAR
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the transcriptionally inactive heterochromatin or the action of enhancers and
repressors (Recillas-Targa, Valadez-Graham et al. 2004). As an example, the
best-characterized insulator, cHS4 (chicken β-globin hypersensitive site 4), has
been shown to stabilize transgene expression over a long period of time (Pikaart,
Recillas-Targa et al. 1998) and facilitate efficient integration of expressed
sequences (Recillas-Targa, Valadez-Graham et al. 2004). Similar to insulators,
STARs (stabilizing and antirepressor elements) are specifically used to block
repression. Another type of DNA sequence, known as the ubiquitous chromatin
opening element (UCOE) is derived from promoters of ubiquitously expressed
genes. These elements have been shown to improve and stabilize transgene
expression in a tissue-nonspecific manner, most likely through the maintenance
of an active chromatin structure (Williams, Mustoe et al. 2005). Matrix attachment
regions (MAR) are elements that mediate the attachment of chromosome to the
nuclear matrix and, as such, are also widely used DNA for sustained transgene
expression. These elements have also been shown to counteract position
dependent insertion effects and prevent transgene silencing in a variety of cell
types and transgenic animals (reviewed by Harraghy and colleagues (2008)).
Expression of bacterial bioluminescence in mammalian cells
The distinct autonomous feature of the bacterial bioluminescence system and
its extensive use a bacterial whole-cell biosensor has intrigued researchers to
expand the applications of lux to eukaryotic reporters. Although many groups
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have attempted to express the lux system in eukaryotic organisms, it was almost
30 years after the first demonstration of exogenous expression of lux and
acquired bioluminescent phenotype in E. coli (Engebrecht, Nealson et al. 1983)
that lux-based autonomous bioluminescence had been successfully expressed in
mammalian cells (Close, Patterson et al. 2010). One of the hurdles limiting lux
expression in the eukaryotic cellular background is the number of genes needed
to be simultaneously expressed. Unlike in prokaryotes, where translation of
multiple adjacent genes from one promoter is common, gene expression in
eukaryotes often requires that each individual gene be regulated by its own
promoter. This is because eukaryotic translation normally requires the presence
of a methyl-7-G(5’)pppN cap at the 5’ end of the mRNA prior to recognition by the
translation initiation complex at the start of peptide synthesis (Pestova,
Kolupaeva et al. 2001). To overcome this limitation, many groups have attempted
to express the Vibrio harveyi luciferase heterodimer (encoded by the luxA and
luxB genes) either as fusion proteins (Kirchner, Roberts et al. 1989; Pazzagli,
Devine et al. 1992) or as individual subunits using a dual promoter expression
vector (Koncz, Olsson et al. 1987). However, it was determined that these
strategies were not capable of expressing the LuxA and LuxB proteins at a
functional level in mammalian cells, possibly due to improper dimerization and
thermo-liability of the V. harveyi luciferase at the optimal mammalian growth
temperature. Alternatively, Patterson et al. demonstrated that expression of the
luxA and luxB genes from the insect pathogen, P. luminescens as a single
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bicistronic transcript with the aid of an IRES element was stable and functional at
37°C in human cells (Patterson, Dionisi et al. 2005). This expression format
allowed bioluminescence production at a detectable level in whole cell extracts
upon the addition of an aldehyde substrate. It was further demonstrated that the
difference in codon usage patterns between bacteria and mammalian species
was a limiting factor for efficient translation of bacteria-derived gene sequences
in the eukaryotic cellular background. By optimizing the lux gene sequences to
mimic the human codon usage pattern without altering the amino acid sequences,
bioluminescence increased by more than two orders of magnitude.
Despite the successful expression of the bacterial luciferase dimer, it was
also determined that functional expression of the remaining genes in the lux
cassette is essential for substrate-free bioluminescence production, as the
human cellular background does not provide sufficient substrates to be
scavenged by the LuxAB proteins to produce light autonomously. By applying
similar strategies used for the expression of the luxAB genes, Close et al.
demonstrated that co-expression of human optimized P. luminescens luxCDE
and V. harveyi flavin reductase frp genes in an IRES-mediated bicistronic bidirectional vector was capable of providing adequate myristyl aldehyde substrate
and FMNH2 co-factor for the bioluminescence reaction in mammalian cells (Close,
Patterson et al. 2010). Codon optimization was shown to be a significant
contributing factor to the overall bioluminescent output, as expressing the human
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optimized versions of these genes led to a 9-fold increase in signal intensity as
compared to expression from their wild type counterparts. It was further revealed
that cytosolically available FMNH2 was a limiting reagent for the bioluminescent
reaction in mammalian cells since supplementation with exogenous flavin
oxidoreductase resulted in a greater increase (151-fold vs. 58-fold) in in vitro
bioluminescent

production

from

cell

extracts

than

that

of

aldehyde

supplementation. This result was consistent with a previous finding that addition
of the frp gene improved autonomous bioluminescence up to 5.5-fold in S.
cerevisiae expressing the luxCDABE genes (Gupta, Patterson et al. 2003).
Therefore, it was believed that including the frp gene was an effective strategy
and contributed significantly to the overall bioluminescent output.
Common bioluminescent reporter proteins for mammalian applications
Despite being widely used as a prokaryotic bioreporter, the lux system has yet
to be widely employed for use in the mammalian cellular background. Currently,
the most commonly used bioluminescent reporter proteins in mammalian cells
are firefly luciferase and Renilla luciferase. These bioluminescent proteins are
gaining preference over their fluorescent counterparts because the lack of
endogenous bioluminescent reactions in mammalian tissue allows for near
background-free imaging conditions whereas the prevalence of fluorescently
active compounds in these tissues can interfere with target resolution upon
exposure to the fluorescent excitation wavelengths required for the generation of
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signal output.
Firefly luciferase (FLuc) is the best studied of a large number of luminescent
proteins to be discovered in insects. The genes utilized in most studies are those
from the common North American firefly, Photinus pyralis (Fraga 2008). The
FLuc protein catalyzes the oxidation of reduced luciferin in the presence of ATPMg2+ and oxygen to generate CO2, AMP, PPi, oxyluciferin, and yellow-green light
at a wavelength of 562 nm. This reaction was originally reported to occur with a
quantum yield of almost 90% (Conti, Franks et al. 1996), however, advances in
detection technology have revealed that it is likely actually closer to 40% (Ando,
Niwa et al. 2008). Nonetheless, the sufficiently high quantum yield of this reaction
is well suited to use as a reporter with as few as 10−19 mol of luciferase (2.4 × 105
molecules) able to produce a light signal capable of being detected (Gould and
Subramani 1988).
Renilla luciferase (RLuc) undergoes a similar method of action to produce
bioluminescence. The gene encoding for this protein was originally isolated from
the soft coral Renilla reniformis and displays blue-green light at a wavelength of
480 nm, however, additional red-shifted variants have been created as well that
luminesce at higher wavelengths to promote increased tissue penetration of the
luminescent signal. Regardless of the emission wavelength, the RLuc proteins all
catalyze the oxidative decarboxylation of its substrate coelenterazine in the
presence of dissolved oxygen and perform this reaction at a quantum yield of 7%
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(Lorenz, McCann et al. 1991). Because of its dissimilar bioluminescent signal
and substrate, RLuc is often used simultaneously with FLuc for multiple reporter
studies.
The advantages and disadvantages of FLuc, RLuc, and lux are compared in
Table 3. It is clear that improved bioluminescent sensing technology that offers
substrate-free and non-invasive monitoring will be beneficial to a variety of
research fields. The historical review of lux expression in surrogate hosts
presented in this chapter demonstrates that developing lux-based human cell
bioreporters will fulfill this niche.
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Table 3. Comparison of the lux system with other commonly used bioluminescent
proteins.
Reporter
Firefly and click
beetle luciferase
• D-luciferin

substrate

Renilla and
Gaussia
luciferase
• Coelenterazine

substrate

Bacterial
luciferase

Advantages
• High sensitivity and low

signal-to-noise ratio
• Quantitative correlation
between signal strength and
cell numbers
• Low background in animal
tissues
• Variations of firefly luciferase
(stabilized and red-shifted) and
click beetle luciferases (red
and green) are available
• Different colors allow
multi-component monitoring
• High sensitivity
• Quantitative correlation

Disadvantages
• Requires exogenous

luciferin addition

• Fast consumption of

luciferin can lead to
unstable signal
• ATP and oxygen
dependent
• Currently not practical for
large animal models

• Requires exogenous

coelenterazine addition

between signal strength and
cell numbers
• Stabilized and red-shifted
Renilla luciferase are available
• Secretion of Gaussia
luciferase allows for subjectindependent bioluminescence
measurement

• Low anatomic resolution
• Increased background

• High sensitivity and low

• Bioluminescence at 490

signal-to-noise ratio
• Quantitative correlation
between signal strength and
cell numbers
• Fully autonomous system, no
requirement for addition of
exogenous substrate
• Noninvasive
• Stable signal
• Rapid detection permitting
real-time monitoring

due to oxidation of
coelenterazine by serum
• Oxygen dependent
• Fast consumption of
coelenterazine can lead
to unstable signal
• Currently not practical for
large animal models

nm prone to absorption in
animal tissues
• Low anatomic resolution
• NADPH and oxygen
dependent
• Not as bright as other
luciferases
• Currently not practical for
large animal models

Originally published in and used with permission from (Close, Xu et al. 2011).
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CHAPTER II
Development of a Single Polycistronic Vector System for Single
Promoter Driven Expression of the lux Cassette in Human Cell
Lines
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Introduction
Setting the bacterial bioluminescence (lux) system apart from other
luminescent or fluorescent reporter proteins is its capability to produce light
autonomously without the need for substrate addition or external optical
excitation. Although the lux reporter system has been used extensively in
prokaryotic whole-cell biosensors for environmental assessment (Eltzov and
Marks 2011; Ripp, Layton et al. 2011; Shin 2011; Singh, Abhilash et al. 2011; Xu,
Close et al. 2012) and for non-invasive visualization of pathogen infection in
living animals (Francis, Joh et al. 2000; Francis, Yu et al. 2001; Cronin, Sleator et
al. 2008), development of an autonomous mammalian bioluminescent system
has long been desired. Unlike the single gene-based firefly luciferase (FLuc) and
fluorescent protein (GFP and its color variants) systems which are two of the
most widely employed reporter systems in mammalian applications, the lux
system requires concurrent expression of six genes (luxCDABEfrp) for substratefree bioluminescence production in human cell lines. The number of genes that
need to be expressed simultaneously have been the major hurdle for expanding
the lux system into mammalian cell-based applications.
The simultaneous expression of multiple exogenous genes in eukaryotic cells
is complicated relative to their prokaryotic counterparts due to fundamental
differences in the genetic architecture and gene expression mechanisms
between the two domains. Unlike polycistronic expression of multiple genes often
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found in bacteria, gene expression in the eukaryotic cellular background normally
requires that each gene be regulated by its own promoter (Pestova, Kolupaeva et
al. 2001). Several strategies have been developed to overcome this limitation.
On the most basic level, it is possible to express each gene independently from
its own promoter, either through the introduction of multiple vectors, or
introduction of a single vector containing multiple promoters. However, each
gene is transcribed separately, which may lead to imbalanced gene expression
(Emerman and Temin 1986). Alternatively, two genes can be translationally
fused in one open reading frame (ORF) and transcribed from a single promoter.
While it ensures coexpression, decreased protein activities have been observed
(Thomas and Maule 2000). Nevertheless, none of these techniques is suitable
for expressing more than two proteins.
One method to transcriptionally fuse two or more genes and still allow for
separate translation of each gene is to use internal ribosome entry site (IRES)
elements. First identified in poliovirus and encephalomyocarditis virus RNA (Jang,
Krausslich et al. 1988; Pelletier and Sonenberg 1988), IRES elements are RNA
sequences or DNA sequences that upon transcription into mRNA, form a
secondary structure that attracts and binds a ribosome to internally initiate
translation of the following cistron in a cap-independent manner (Baird, Turcotte
et al. 2006). Unlike in fusion proteins, expression of each IRES-linked gene is an
independent translation event, thus not interfering with post-translational
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interactions between the proteins of interest. For instance, while expressing the
bacterial luciferase (LuxAB heterodimer) as fusion proteins was not successful,
the use of an IRES-mediated bicistronic vector has been demonstrated to be an
effective strategy for generating functional luciferase in human cell lines
(Patterson, Dionisi et al. 2005). Polycistronic expression of up to three (Li and
Zhang 2004) and four (Bouabe, Fassler et al. 2008) genes from a single
promoter have also been made possible with tandem IRES elements. However,
the IRES elements have been criticized for their relatively large size (in the range
of 500 bp) and lower expression of the downstream genes than the upstream
genes (Mizuguchi, Xu et al. 2000).
An alternative method for polycistronically expressing multiple genes in
mammalian cells is to use viral 2A elements. Originally identified in foot-andmouth disease virus (FMDV), 2A elements are in-frame linker regions that
separate two genes driven off a single promoter. A highly conserved
D(V/I)EXNPGP motif at the C-terminus of these peptides is essential for the
function of 2A peptides, as the last G-P bond is “cleaved” during translation.
Although it was originally hypothesized that the cleavage was mediated by a
proteinase either encoded in the viral genome or in the mammalian host cells, it
was demonstrated later that ribosome skipping, rather than proteinase cleaving,
is the mechanism for how 2A peptides function (Donnelly, Luke et al. 2001).
During translation of the 2A peptides, the ribosome skips the synthesis of the last
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Gly-Pro peptide bond at the C-terminus. However, translation of the downstream
gene is continued regardless of this missing bond. Two advantages of the 2A
elements compared to the IRES elements are their short length (averaging 18 –
22 amino acids) and high efficient stoichiometric expression of flanking genes (de
Felipe 2002). To date, 2A elements have been identified in Picornaviruses, Type
C rotaviruses and insect viruses, with those from FMDV (F2A), equine rhinitis A
virus (E2A), porcine teschovirus-1 (P2A), and Thoseaasigna virus (T2A) being
mostly characterized (Szymczak and Vignali 2005). The ability of the 2A
elements to express up to four genes from a single transcript in mammalian cells
has been previously demonstrated by many groups (Szymczak, Workman et al.
2004; Carey, Markoulaki et al. 2009).
Autonomous bioluminescence production in human cell lines requires
concurrent expression of the luciferase (luxAB), the enzymes for synthesis of the
aldehyde substrate (luxCDE), and the flavin oxidoreductase (frp) for recycling the
FMNH2 co-factor. The number of genes that need to be delivered and expressed
at a functional level represents a challenging hurdle. A two plasmid expression
system has been recently developed for expressing the lux cassette in human
embryonic kidney (HEK293) cells (Close, Patterson et al. 2010). In this system,
the luxAB genes are expressed from an IRES-mediated bicistronic vector,
whereas the luxCDEfrp genes are assembled into a second multi-bicistronic
vector. Specifically, a total number of three promoters are employed to regulate
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gene expression. One optimization to the two plasmid system would be the
delivery of all six genes within the context of a single polycistronic vector. It was
therefore hypothesized that, through the use of viral 2A peptides as linker regions,
it will be possible to simultaneously express up to six genes (the luxCDABEfrp
gene cassette) under the regulation of a single promoter for autonomous
bioluminescent production in human cell lines. This method of expression would
as well reduce the number of required transfection steps required for production
of bioluminescent cell lines from two to one. This would therefore reduce both the
time and effort required to develop additional bioluminescent cell lines, and
provide a more simplistic means for regulating bioluminescent production. It is
demonstrated here that, through the use of viral-derived 2A elements as linkers,
the luxCDABEfrp gene cassette can be functionally expressed to produce
bioluminescence autonomously from a single promoter in human cell lines. The
polycistronic

single

vector

system

has

also

been

shown

to

improve

bioluminescence yield above the previously validated two plasmid expression
system.

Materials and Methods
Human cell lines and plasmid constructs used in this study are summarized in
Table 4.
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Table 4. Cell lines and plasmid constructs used in this study.
Cell line

Cell type (Medium)

Source

HEK293

Human embryonic kidney cells (Dulbecco's Modified
Eagle Medium (DMEM))

ATCC

HEK293 Tet-On

HEK293 cells stably expressing the tetracyclineregulated transactivator

HEK293
/pLuxAB:pLuxCDEfrp

Bioluminescent HEK293 cells constructed using the
two plasmid expression system

Close et al.
(2010)

HEK293/pIRES LuxAB

HEK293 cells stably expressing pIRES LuxAB

(Patterson,
Dionisi et al.
2005)

HEK293/pIRES
LuxAB/hygro

HEK293 cells stably expressing pIRES LuxAB/hygro

This study

HEK293 ECO

Bioluminescent HEK293 cells constructed by retransfecting HEK293/pIRES LuxAB/hygro with pCMV
Lux

This study

T-47D

Human breast carcinoma cells (RPMI-1640)

T-47D/Lux

Bioluminescent T-47D cells stably expressing pCMV
Lux

MCF-7

Human breast carcinoma cells (DMEM)

ATCC

HCT-116

Human colorectal carcinoma cells (McCoy’s 5A)

ATCC

Plasmid

Description

Clontech

ATCC
This study

Source

pcDNA3.1/hygro(+)

Mammalian expression vector containing a CMV IE
promoter and a hygromycin resistance gene

Invitrogen

PCR4-TOPO

TOPO TA cloning vector for cloning of PCR products
generated with 3' A overhangs

Invitrogen

pTRE-Tight-BI

Bi-directional mammalian expression vector
containing two divergent CMV IE minimal promoters
separated by a tetracycline response element (TRE)

Clontech
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Table 4. Continued.
Plasmid

Description

Source

pd2EGFP-1

Promoter-less vector containing a d2EGFP reporter
gene

Clontech

pIRES LuxAB

IRES-mediated bicistronic vector for expression of
the bacterial luciferase (luxAB) from a single
cytomegalovirus immediate early (CMV IE) promoter

(Patterson,
Dionisi et al.
2005)

pEF Lux

Polycistronic vector containing 2A-linked
luxCDABEfrp expressed from a human elongation
factor 1-α (EF1-α) promoter

This study

pCMV Lux

Polycistronic vector containing 2A-linked
luxCDABEfrp expressed from a CMV IE promoter

This study

pLux-1

Promoter-less 2A-linked polycistronic luxCDABEfrp
vector for downstream cloning

This study

p2A LuxAB

2A-mediated bicistronic vector for expression of
luxAB from a single CMV IE promoter

This study

p2A LuxCDEfrp

2A-mediated polycistronic vector for expression of
luxCDEfrp from a single EF1-α promoter

This study

pEF LuxCDA-IRESLuxBEfrp

Polycistronic vector containing 2A-linked luxCDE and
2A-linked luxBEfrp sequences separated with an
IRES element

This study

pCR4-luxAIRES

pCR4 TOPO vector hosting the luxA-IRES sequence
cloned from pIRES LuxAB

This study

pCR4-MluI/CMV/SalI

pCR4 TOPO vector hosting the CMV IE promoter
sequence

This study

pCR4-AIB

pCR4 TOPO vector hosting the luxA-IRES-luxB
sequence for construction of pIRES LuxAB/hygro

This study
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Table 4. Continued.
Plasmid

Description

Source

pIRES LuxAB/hygro

pCDNA3.1/hygro(+) harboring the luxA-IRES-luxB
sequence

This study

pCR4LuxAB

pCR4 TOPO vector hosting the luxA-IRES-luxB
sequence with an introduced 5' AgeI site for
construction of pERE3-TATA LuxAB

This study

pERE3-TATA LuxAB

IRIES-mediated bicistronic expression of luxAB from
an estrogen responsive promoter consisting of three
tandems of estrogen response element (ERE) and
an adenovirus E1B minimal TATA promoter

This study

pERE3-TATA Lux

Polycistronic vector containing 2A-linked
luxCDABEfrp expressed from three tandems of ERE
and a TATA promoter

This study

pERE3-CMVm Lux

Polycistronic vector containing 2A-linked
luxCDABEfrp expressed from three tandems of ERE
and a CMV IE minimal promoter

This study

pTet Lux

Single polycistronic vector containing 2A-linked
luxCDABEfrp expressed from a tetracycline
response element and its associated CMV IE
minimal promoter

This study
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Design and construction of 2A-linked expression vectors
Divergent viral-derived 2A elements were used to link adjacent lux genes in
the polycistronic single vector. Several significant changes had to be made to the
lux genes prior to their incorporation into the new single vector expression
system. To reduce the likelihood of homologous recombination events, each of
the viral 2A elements was sourced from a different virus to avoid the
incorporation of repetitive DNA sequences (Table 5). These 2A elements were
chosen because they are well-characterized and widely used by various
researchers. Furthermore, having been previously demonstrated by Szymczak
and colleagues (Szymczak, Workman et al. 2004) that incorporation of flexible
linker regions upstream of the 2A elements leads to increased separation
efficiency, each 2A element was proceeded by a Gly-Gly-Gly-Ser-Gly-Gly-Gly
sequence. Finally, because the 2A linker regions permit continuous translation of
the mRNA to protein, the stop codons of all lux genes except for the gene most
distal from the promoter were removed. These modifications allowed for the
synthetic assembly of a single DNA construct consisting of luxC-flexible linker-2A
element-luxD-flexible

linker-2Aelement-luxA-flexible

linker-2A

element-luxB-

flexible linker-2A element-luxE-flexible linker-2A element-frp. The lux genes were
organized in such a way to replicate their orders within the lux operon as found in
their native bacterial host.
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Table 5. Viral 2A elements used for polycistronic expression of the lux genes.
2A
element

Virus source

DNA sequence (5' → 3')

Upstream
gene

F2A

Foot and mouth
disease virus

CAGCTGTTGAATTTTGACCTTCTCAAGTTGG
CGGGAGACGTGGAGTCCAACCCAGGGCCC

luxC

E2A

Equine rhinitis A
virus

CAGTGTACTAACTACGCTTTGTTGAAACTCG
CTGGCGATGTTGAAAGTAACCCCGGTCCT

luxD

Ta2A

Synthetic version of
wild type T2A

GAAGGTAGGGGTTCATTATTGACCTGTGGA
GATGTCGAAGAAAACCCAGGACCC

luxA

P2A

Porcine teschovirus

GCGACAAACTTTAGCTTGCTGAAGCAAGCT
GGTGACGTTGAGGAGAATCCCGGACCA

luxB

T2A

Thosea asigna
virus

GAGGGCAGAGGAAGTCTTCTAACATGCGGT
GACGTGGAGGAGAATCCCGGCCCT

luxE
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This sequence was assembled de novo by GeneArt and cloned into the
human elongation factor 1-α (EF1-α) promoter driven pEF/myc/nuc vector
(Invitrogen) using compatible NcoI and XbaI restriction sites to create the vector
pEF Lux (Figure 2). It is important to note that, during the synthesis process, the
removal of intervening restriction and regulatory sequences was performed
according to standard GeneArt synthesis protocols, and the codon optimization
process was re-performed on each of the lux genes to reflect updated codon
usage patterns and improved codon optimization software that has been
developed since the previous optimization took place in 2004. This resulted in
some changes in the DNA sequence of luxAB and minor changes in luxC, luxD,
luxE, and frp gene sequences, but did not in any way alter the resultant protein
products (Table 6).
2A-linked vectors p2A LuxAB and p2A LuxCDEfrp were also constructed for
comparison purposes. To construct vector p2A LuxAB, the luxA-Ta2A-luxB
sequence was synthesized de novo commercially (GeneArt) and cloned into the
original pIRES LuxAB vector to replace the luxA-IRES-luxB sequence. The
substrate processing vector p2A LuxCDEfrp was generated through a series of
modifications on pEF Lux. First, the E2A-luxA-Ta2A-luxB sequence was removed
by blunt end restriction enzymes PmeI and EcoRV, followed by a ligation reaction
to join both the open ends of the remaining sequence to form a circular vector.
This intermediate vector, however, was frame shifted for luxE and frp genes as a
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Figure 2. A schematic representation of the single promoter
polycistronic vector for lux expression in human cell lines.
Viral 2A elements are used to link adjacent lux genes for polycistronic
translation. The stop codons of all lux genes except for the gene most
distal from the promoter (frp) are removed to allow for continuous
translation. The lux genes are organized to replicate their orders within the
lux operon as found in their native bacterial host.
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Table 6.Comparison of previous and updated versions of codon optimized gene
sequences.
Gene

DNA identity to previous optimization
(Close, Patterson et al. 2010)

luxA

85%

luxB

85%

luxC

95%

luxD

95%

luxE

93%

frp

99%
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result of removing the luxAB sequence. Site-directed mutagenesis was
subsequently performed to delete 2 bp between luxD and luxE using the
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent) to allow for inframe translation of the LuxE and Frp protein. The final vector was designated
p2A LuxCDEfrp.
To compare 2A- and IRES- mediated expression, vector pEF Lux was also
modified to replace the Ta2A linker between luxA and luxB with an IRES element.
Because the IRES element attracts a separate ribosome to initial translation of
the downstream ORF, it requires that the upstream ORF contains a stop codon
for proper translation termination. Therefore, instead of simply replacing the
Ta2A sequence with an IRES sequence, the luxA (with stop codon)-IRES
sequence

was

first

PCR

amplified

using

primers

5'-

ATGAAGTTCGGCAACTTCCTG-3' and 5'-GTGGCAAGCTTATCATCGTG-3' and
cloned into pCR4-TOPO vector (Invitrogen) to create pCR4-luxAIRES. The luxA
(without stop codon)-Ta2A sequence was then removed from pEF Lux using
blunt end restriction enzymes SwaI and Eco47III and replaced by the luxA (with
stop codon)-IRES sequence cut from pCR4-luxAIRES using blunt end restriction
enzymes PmeI and SnaBI, generating vector pEF LuxCDA-IRES-LuxBEfrp..
To facilitate future modification of the single lux vector, the EF1-α promoter
was removed by restriction digest with Acc65I and NcoI and replaced by a 92 bp
sequence containing multiple restriction sites, creating a promoter-less vector
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pLux-1. To construct human cytomegalovirus immediate early (CMV IE) promoter
regulated lux vectors, the promoter sequence was PCR amplified using pIRES
LuxAB as template with added 5’-MluI and 3’-SalI site and cloned into pCR4 to
generate pCR4-MluI/CMV/SalI. The promoter sequence was then removed from
pCR4-MluI/CMV/SalI using MluI and SalI and cloned into similarly digested pLux1 to generate pCMV Lux.
Human cell culture and transfection
Human cell lines used in this study are listed in Table 4. All cell lines were
originally obtained from American Type Culture Collection (ATCC) and
maintained in recommended growth medium supplemented with 10% fetal
bovine serum (FBS) (Hyclone), 0.01 mM non-essential amino acids (Invitrogen),
1X antibiotic-antimyotic (Invitrogen) and 0.01 mM sodium pyruvate (Invitrogen).
Cells were cultured at 37°C in a 5% CO2 environment with medium being
refreshed every 2 - 3 days. Cells were passaged regularly upon reaching 80%
confluence.
E. coli TOP10 cells (Invitrogen) were used to host and propagate plasmids
used in this study. E. coli cells were routinely grown in Luria Bertani (LB) broth at
37°C with 200 rpm continuous shaking. Ampicillin at a final concentration of 100
µg/ml was used for selection and maintenance of successfully transformed cells.
Transfections were carried out in 6-well tissue culture plates (Corning). The
day prior to transfection, cells were plated at a density of 5 × 105 cells/well (for
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HEK293 and HCT-116 cells) or 7.5 × 105 cells/well (for T-47D and MCF-7 cells)
in each well. Vector DNA purified from overnight E. coli culture using PureYield
Plasmid Purification System (Promega) was introduced into the cells using
Lipofectamine 2000 transfection reagent (Invitrogen) following manufacturer’s
instructions.
Bioluminescent detection in transiently transfected cells
To validate the effectiveness of the 2A-linked polycistronic lux vectors (pEF
Lux and pCMV Lux), bioluminescence production was evaluated in transiently
transfected HEK293, T-47D, MCF-7 and HCT-116 human cell lines. Twenty-four
hours post transfection, cells were washed with sterile phosphate buffered saline
(PBS) and harvested in growth medium. Approximately 1 × 106 transfected cells
or untransfected cells (as negative controls) were plated in 1 ml volume in
triplicate wells in a black 24-well plate for imaging. Bioluminescent production
was measured in the IVIS Lumina imaging system (Perkin-Elmer) using a 10 min
integration time every 30 min for at least 20 hours. Photon counts were analyzed
with Living Image 3.2 software (Perkin-Elmer) and reported as average radiance
in photons(p)/second(s)/cm2/steridian(sr).
Polycistronic lux expression using a single vector was also compared to a
similarly constructed two plasmid expression system. Equal numbers of cells
were transfected with pEF Lux or co-transfected with 2A-linked vectors p2A
LuxAB and p2A LuxCDEfrp. Twenty-four hours post transfection, cells were washed
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and PBS, harvested in growth medium and tested for bioluminescent production
as described above.

Results
Expression of the 2A-linked polycistronic single lux vector in human cell
lines
To test if the bacterial bioluminescence gene cassette (luxCDABEfrp) can be
delivered using a single vector and expressed functionally under the regulation of
a single promoter in human cell lines, a 2A-linked polycistronic expression vector
was designed and synthesized. The effectiveness of the 2A-linked vector pEF
Lux for the expression of bacterial bioluminescence was tested in HEK293, T47D, MCF-7, and HCT-116 cells. Cells transfected with the single lux vector
emitted bioluminescence at a detectable level (Student’s t test p < 0.05)
compared to untransfected control in all tested cell types (Figure 3A). However,
the expression efficiency was not consistent across different cell types. In 1 × 106
transfected HEK293 or T-47D cells, maximal bioluminescence was observed at
2.13 (± 0.10) × 103 p/s/cm2/sr and 2.37 (± 0.36) × 103 p/s/cm2/sr, respectively. On
the other hand, expression of the same vector in the other two cell lines was
significantly lower than that in HEK293 and T-47D cells, with maximal flux of 4.08
(± 0.22) ×102 p/s/cm2/sr and 3.96 (± 0.16) × 102 p/s/cm2/sr being produced in
equal numbers of transfected MCF-7 and HCT-116, respectively.
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A

B

Figure 3. Polycistronic expression of the lux cassette in a single
vector in human cell lines.
(A) Maximal bioluminescence yield from equal numbers (1 × 106) of
shown cell lines transfected with the polycistronic vector pEF Lux. (B) 24hour bioluminescent profiles of the transfected cells displayed as fold
change over untransfected control (n=3, mean ± standard error).
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The substrate-free nature of the lux system permitted near real-time,
continuous monitoring of bioluminescent production over time on the same cell
population without sample destruction or substrate addition. As shown in Figure
3B, different cell types displayed varying light production dynamics. In
transfected HEK293 cells, a significant level of bioluminescence (p < 0.05) was
consistently observed for the first 20 hours with intermittently detectable light
production between 20 and 24 hours. Peak bioluminescence at 6.1 (± 0.3)-fold
over control was detected ~ 2.5 hours post plating, followed by a rapid decrease
to near-background level. Transfected T-47D cells, though displaying similar
maximal light production to HEK293 cells (Figure 3A), produced peak
bioluminescence approximately 8 hours post plating. Unlike the rapid decrease in
HEK293 cells, bioluminescent flux remained relatively stable for the remaining
imaging period, with a slight reduction to 67% of maximal flux at 24 hours post
plating. Despite the significantly lower overall signal intensity, the transfected
MCF-7 and HCT-116 cells displayed a comparable bioluminescent profile over
the imaging period to that of the HEK293 and T-47D cells, respectively.
Determination of an optimal promoter for polycistronic lux expression in
multiple human cell lines
In order to choose a promoter for optimal bioluminescent production across
different cell types, and to test the sub-hypothesis that insufficient transcription of
the lux genes to mRNA is responsible for the low bioluminescent flux observed in
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MCF-7 and HCT-116 cells (Figure 3A), the EF1-α promoter was substituted with
a CMV IE promoter. The CMV IE promoter-driven expression of the 2A linked lux
genes yielded significantly higher bioluminescent output in all four tested cell
types,

especially

in

MCF-7

and

HCT-116

cells,

displaying

maximal

bioluminescence of 13.0 (± 0.6)-fold and 28.5 (± 5.1)-fold over untransfected
background, respectively (Figure 4A). In each cell line, the bioluminescent profile
driven by the CMV IE promoter was comparable to that expressed from the EF1α promoter (Figure 4B), suggesting that the 2A peptide-mediated translation
activity was not promoter-dependent.
Effect on bioluminescent production of replacing the 2A element
separating the luxA and luxB sequences with an IRES element
To test the hypothesis that 2A peptides are more efficient for polycistronic
expression of multiple genes than are IRES elements, the Ta2A sequence linking
the luxA and luxB genes in pEF Lux was replaced by a previously validated and
commonly used encephalomyocarditis virus IRES element to create pEF LuxCDAIRES-LuxBEfrp. To allow for proper termination of peptide synthesis of the genes
upstream of the IRES element, the luxA sequence was also modified to include a
stop codon at the C-terminus without altering the amino acid sequence.
Bioluminescent production was compared in HEK293 cells transfected with either
pEF Lux or pEF LuxCDA-IRES-LuxBEfrp; two otherwise identical vectors that linked
the luxCDE and luxBEfrp sequences with either a 2A or an IRES element.
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A

B

Figure 4. Bioluminescent profiles from different promoter driven lux
expression in a variety of human cell lines.
(A) Comparison of maximal bioluminescence yield from equal numbers (1 ×
106) of shown cell lines transfected with pEF Lux or pCMV Lux. (B) 20-hour
bioluminescent profiles of the transfected cells displayed as fold change over
untransfected control (n=3, mean ± standard error).
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Transfection of the IRES-containing polycistronic lux vector yielded maximal
bioluminescence of 7.44 (± 0.69) × 102 p/s/cm2/sr, which was only approximately
35% of that produced from the 2A-only pEF Lux expression vector (Figure 5).
Comparison of single and dual vector expression of the lux cassette
Having demonstrated the effectiveness of the single vector expression
system for autonomous bioluminescence, it was necessary to compare the
efficiency of this new expression format to that of the previously demonstrated
dual vector system. To avoid biased translational efficiencies between 2A and
IRES elements as well as varying efficiencies between transient and stable
expression,

the

previously

characterized

stable

bioluminescent

HEK293/pLuxAB:pLuxCDEfrp cells (Close, Patterson et al. 2010) were not included
for comparison. Alternatively, 2A-linked vectors p2A LuxAB and p2A LuxCDEfrp
were constructed and co-transfected for transient expression analysis. As shown
in Figure 6, the single vector expression format was capable of producing
significantly higher bioluminescent output than the dual vector system in HEK293.
Maximal bioluminescent flux (photons/second) emitted from the two plasmid
system was approximately 50-60% of that from equal number of cells transfected
with the single vector over the same surface area. It is important to note that the
luxAB genes in p2A LuxAB were driven by a CMV IE promoter, whereas the EF1α promoter was used in the single vector and the substrate processing vector
p2A LuxCDEfrp. Having demonstrated above that the CMV IE promoter had a
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Figure 5. Replacing the 2A element linking luxA and luxB with an
IRES element significantly reduced bioluminescent production in
HEK293 cells.
Comparison of maximal bioluminescence yield from HEK293 cells
transfected with pEF Lux or pEF LuxCDA-IRES-LuxBEfrp (n=3, mean ±
standard error).
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Figure 6. Comparison of single vector (pEF Lux) and dual vector (p2A
LuxAB and p2A LuxCDEfrp) expression of the lux cassette in HEK293 cells.
Comparison of maximal bioluminescence yield from equal numbers (1 × 106)
of HEK293 transfected with pEF Lux or co-transfected with p2A LuxAB and
p2A LuxCDEfrp (n=3, mean ± standard error).
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higher transcription activity than the EF1-α promoter in both cell types, it was
speculated that bioluminescence expression from the dual vector format would
be even lower had the luxAB genes been regulated by the EF1-α promoter.

Discussion
Since the first case of expressing bacterial bioluminescence genes
exogenously in a foreign host (Engebrecht, Nealson et al. 1983), the last three
decades have witnessed a growing interest in developing the lux cassette into an
autonomous reporter system in both prokaryotic and eukaryotic cells. While the
lux system has become one of the most extensively used reporter systems in
prokaryotic whole-cell bioreporters (Xu, Close et al. 2012), its expression in
mammalian cells has only been recently demonstrated (Close, Patterson et al.
2010) and is still emerging. The major obstacles for the lux system to be adapted
as an autonomous mammalian reporter system include 1) low translation
efficiency of the wild type lux genes by the mammalian protein synthesis
machinery, 2) limited FMNH2 availability in mammalian cells, and 3) the number
of genes that need to be expressed for autonomous bioluminescent production.
While the first two hurdles have been overcome by optimizing the gene
sequences to match the host codon usage pattern (Patterson, Dionisi et al. 2005)
and co-expressing an additional frp gene for improved FMNH2 recycling (Gupta,
Patterson et al. 2003), the requirement of simultaneous expression of six genes
remains challenging. The first demonstration of autonomous bioluminescent
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expression in a human cell line employed a two plasmid expression strategy,
where the luxAB genes are expressed bicistronically through an IRES element in
one vector and the luxCDEfrp genes are assembled in a second vector by
separating the four genes into two transcription units, each containing its own
promoter and two ORFs separated by an IRES element. This strategy has been
demonstrated to express all six genes at a functional level to provide sufficient
luciferase, aldehyde and FMNH2 for autonomous light production (Close,
Patterson et al. 2010). However, development of stable bioluminescent
mammalian cell lines can be complicated by the necessary transfection steps to
co-transfect two plasmids. It is evident that assembling all six genes in a single
vector would simplify this process.
Two widely used elements for polycistronic expression of multiple proteins in
mammalian cells are the IRES elements, employed by the previously
characterized bioluminescent human cell line (Close, Patterson et al. 2010), and
the viral 2A peptides. The 2A peptides are superior to the IRES elements for
polycistronic expression of the luxCDABEfrp gene cassette for two reasons. First,
the 2A sequences are shorter (averaging 18 - 22 amino acids or 54-66 bp in DNA)
compared to the approximately 500 - 600 bp long IRES elements, allowing for
easier assembly of large numbers of genes. Second, they have shown high
cleavage efficiency and stoichiometric expression in vivo (Szymczak, Workman
et al. 2004) whereas the IRES elements are criticized for the lower translation
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efficiency of the downstream gene than that of the upstream gene translated in a
cap-dependent manner from the 5' end of the mRNA (Mizuguchi, Xu et al. 2000).
Based on these justifications, it was decided to exploit the 2A elements for lux
expression in a variety of human cell lines.
Although the 2A-mediated single vector polycistronic expression of four
exogenous proteins has been previously reported (Graf, Bojak et al. 2000; Carey,
Markoulaki et al. 2009), their capabilities to express up to six genes remains to
be validated. Especially for bioluminescent expression in human cell lines,
specific concerns such as if the Lux proteins can be produced at a level sufficient
for detectable bioluminescent production still exists. The EF1-α promoter was
initially chosen to drive the transcription of the lux genes since it had been
demonstrated to be consistently strong across different cell types in a systematic
comparison study (Qin, Zhang et al. 2010). In our study, the polycistronic
expression of the 2A-linked lux genes driven by an EF1-α promoter was
successfully demonstrated in HEK293 and T-47D cells but only achieved modest
success in MCF-7 and HCT-116 cells (Figure 3A). Although a significantly
differentiable signal could be detected from background (cells not expressing the
lux genes), the low signal-to-noise ratio (~ 1.2:1 to 1.4:1) limits its application as
a reliable reporter system in these cell lines. It was not clear at this point if the
low signal intensity was a result of inefficient activity of the 2A peptides to
produce independent Lux proteins in these cell types, or caused by the low
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transcriptional activity of the EF1-α promoter or low transfection efficiency.
Because the 2A peptides function independently upon host cellular factors (i.e.,
no proteinase is required for the cleavage), it is less likely that the 2A elements
were selectively deficient in these cells. This hypothesis was approved by the
demonstration of significantly higher bioluminescent output by expressing the lux
genes from the CMV IE promoter (Figure 4A). Although having been
demonstrated to display the most variable strength across cell types and lower
activity compared to the EF1-α promoter in some cases (Qin, Zhang et al. 2010),
the CMV IE promoter displayed a consistently higher activity than the EF1-α
promoter for bioluminescent production in all four cell lines tested here. These
discrepancies can be explained by the different cell lines and reporter genes
employed between the two studies. The only common cells are the HEK293 cells,
in which the CMV IE promoter exhibited a higher activity in both studies.
Nevertheless, it is demonstrated here that the 2A peptides are capable of
mediating polycistronic expression of up to six genes in various human cell lines.
The unique advantage of the lux system is to allow for non-invasive and
continuous monitoring of the same target over time. Bioluminescent profiles
produced in transfected cells were monitored over a 20-hour imaging period
(Figure 4B). Both promoters used to drive gene expression are known for their
constitutive activities, allowing one to relate light production dynamics to either
change in cell numbers, or cellular health and metabolism. Since the doubling
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times of selected human cell lines are greater than 20 hours, the rapid increase
in bioluminescence in the first few hours observed in all four cell types are not
likely caused by cell proliferation. It is speculated that switching from a carefully
controlled 5% CO2 incubator environment to the atmospheric condition in the
imaging chamber causes a rapid increase in the medium pH value, which may
affect the intracellular redox potential and NADPH availability for the
bioluminescent reaction. The inability to control the CO2 level, humidity and air
temperature in the imaging system in combination with the continuing
consumption of nutrients present in the medium, represent a unique situation
where cellular metabolism and health is challenged by unspecified factors whose
effects on living systems cannot be easily detected using the conventional
reporter systems. The substrate-free nature of the lux system eliminates the
requirements of cell destruction or substrate addition, thus permitting the cellular
metabolic response to be visualized continuously in a cell-type dependent
manner. Two of the cancer cell lines (T-47D and HCT-116) responded robustly to
the uncontrolled and/or unfavorable environmental conditions in the imaging
chamber and maintained relatively stable bioluminescence over the 20 h period
(Figure 4B). In contrast, the bioluminescent production in HEK293 and MCF-7
cells gradually decreased to a near-background level after the peak close to the
beginning of the imaging period, suggesting compromised cellular health and
even cell death. While the bioluminescent output of cells expressing lux genes
from the CMV IE promoter was of a greater magnitude than that of the EF1-α
71

promoter, their bioluminescent profiles relative to background were comparable
under the same imaging conditions (Figure 4B), implying that the cellular
metabolic response was not affected by the expression of the Lux proteins.
The advantage of using the 2A elements over the IRES elements for
polycistronic lux expression was confirmed by the reduction in bioluminescent
expression when the 2A sequence linking the luxA and luxB genes was replaced
by an IRES element. The decrease in light production is in agreement with the
criticism that translation of the genes downstream of the IRES element is lower
than that of the upstream genes (Szymczak and Vignali 2005). Specifically, it has
been demonstrated previously that FMNH2 is a major limiting reagent in the
bioluminescent reaction in eukaryotic cells (Gupta, Patterson et al. 2003; Close,
Patterson et al. 2010). Since the frp gene encoding the oxidoreductase for
FMNH2 recycling was downstream of the IRES element and most distal to the
promoter, it is speculated that reduced Frp protein synthesis was an important
contributor to the decreased bioluminescent output.
Expressing the lux genes from a single promoter, along with the use of the 2A
elements for highly efficient stoichiometric protein expression, leads to coupled
transcription and translation of these genes. The more balanced gene expression
provided by the single vector system was able to produce higher bioluminescent
flux than the similarly constructed two promoter/two vector system. Additionally,
cell-to-cell variability in promoter activity and gene expression can interfere with
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the correlation between bioluminescent production and the number of cells
present in a population (Bar-Even, Paulsson et al. 2006; Blake, Balazsi et al.
2006). This variability can be amplified if a phenotype is controlled by multiple
promoters. Therefore, it is speculated that the single promoter expression system
will allow a tighter correlation between bioluminescence and cell numbers
compared to the two plasmid expression system. However, this still remains to
be experimentally assessed.
In conclusion, it is demonstrated here for the first time that through the use of
divergent viral 2A elements, it is possible to express the luxCDABEfrp genes for
autonomous bioluminescent production in a range of human cell lines. The single
vector expression format improves bioluminescent production over the previously
characterized IRES-based two plasmid system, and provides a more simplistic
means for the lux cassette expression in other cell types for non-invasive
continuous monitoring.
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CHAPTER III
Development of an Improved Autonomous Bioluminescent
Human Cell Line with Enhanced lux Expression
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Introduction
Bioluminescent sensing is becoming increasingly applied across a variety of
basic and applied biological research fields due to its low background, high
throughput, and relative ease of operation in detecting cellular processes in cell
culture and living animals (Baker 2010). By using genetically modified cells
containing a reporter protein capable of producing an optical signal, investigators
can visualize a diverse range of biological events, such as tumorigenesis and
cancer treatment (Rehemtulla, Stegman et al. 2000; Venisnik, Olafsen et al.
2006), gene expression and regulation (Rettig, McAnuff et al. 2006; Korpal, Yan
et al. 2009), cell trafficking (Sheikh, Lin et al. 2007; van der Bogt, Sheikh et al.
2008), viral and pathogenic infection (Andreu, Zelmer et al. 2011), protein
stability and function (Laxman, Hall et al. 2002; Wang, Fu et al. 2010), and
protein-protein interactions (Paulmurugan, Umezawa et al. 2002; Pichler, Prior et
al. 2008) (reviewed in (Close, Xu et al. 2011)). To date, the main reporter
proteins used for these applications have been the firefly luciferase (FLuc), the
Renilla

luciferase

(RLuc),

and

the

Gaussia

luciferase

(GLuc).

These

bioluminescent proteins, regardless of their native host organisms, function in a
similar fashion. They catalyze the oxidation of a substrate (luciferin for FLuc and
coelenterazine for RLuc and GLuc) in the presence of oxygen to produce light
(Lorenz, McCann et al. 1991; Verhaegen and Christopoulos 2002; Fraga 2008).
These substrates, however, cannot be synthesized in host cells, and therefore
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must be added exogenously. Due to rapid substrate consumption (Bhaumik and
Gambhir 2002; Inoue, Kiryu et al. 2009), these systems have relatively short
temporal dynamics. Although substrate can be added repeatedly for long term
monitoring, this also introduces unwanted injection errors, especially in whole
animal imaging applications. Meanwhile, these substrates are relatively unstable
and expensive, adding a financial burden to the utilization of these systems
(Close, Hahn et al. 2011).
The newest addition to the mammalian-based bioluminescent sensing
technology is the bacterial bioluminescence (lux) reporter system (Close,
Patterson et al. 2010). This system is intrinsically different from other
bioluminescent systems because of its ability to synthesize/recycle all required
substrates endogenously within the host cells to produce light in a fully
autonomous fashion. This is made possible because the lux system contains
genes (luxCDEfrp) encoding proteins that are capable of providing the substrate
required for light production. Specifically, the luxC, luxD, and luxE gene products
are used for synthesizing and recycling a long chain fatty aldehyde substrate
from endogenous compounds. For efficient light production in mammalian cells, a
sixth gene, frp, encoding a flavin oxidoreductase is also included to facilitate
efficient FMNH2 recycling. Co-expression of these genes together with the
luciferase genes (luxAB) can produce sufficient substrate for autonomous
bioluminescent expression and therefore obviates the step of exogenous
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substrate addition that is essential for the conventional Luc systems.
Since its first expression in mammalian cells, the lux system has proven
useful for cell culture-based in vitro imaging and whole animal in vivo imaging
(Close, Patterson et al. 2010; Close, Hahn et al. 2011). However, as the first
generation of lux-expressing cells, they produce a relatively weak signal
compared to the conventional FLuc systems. In a side-by-side comparison, it has
been determined that ~ 1 × 106 lux-expressing cells produces signal that is
comparable to that produced by only approximately 100 FLuc-expressing cells
(Close, Hahn et al. 2011). The requirement of a large population size to produce
detectable signal significantly restricts adoption of the lux system across a wide
range of bioluminescent imaging applications. It is hypothesized that the human
cellular background is capable of supplying sufficient endogenous substrates for
high level lux-based bioluminescent production and it will be possible to improve
bioluminescent expression through increased gene integration. Here is reported
the development of an improved autonomously bioluminescent HEK293 human
cell line, as well as an optimization strategy that takes advantage of the
previously described two expression system (Close, Patterson et al. 2010) and
the recently developed single polycistronic expression system (Chapter II) for
high level lux expression.
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Materials and Methods
Strain growth and maintenance
Cell lines used in this study included wild type HEK293 cells, HEK293/pIRES
LuxAB cells (Patterson, Dionisi et al. 2005; Close, Patterson et al. 2010),
previously characterized bioluminescent HEK293/pLuxAB:pLuxCDEfrp cells (Close,
Patterson et al. 2010), and HEK293/pIRES LuxAB/hygro (Table 4). Cells were
grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10%
FBS (Hyclone), 0.01 mM non-essential amino acids (Invitrogen), 1X antibioticantimyotic

(Invitrogen)

and

0.01

mM

sodium

pyruvate

(Invitrogen).

HEK293/pIRES LuxAB and HEK293/pLuxAB:pLuxCDEFrp cells maintained in
medium supplemented with Neomycin (Calbiochem) at a concentration of 500
μg/ml.

HEK293/pIRES

LuxAB/hygro

cells

were

maintained

in

medium

supplemented with Hygromycin B (Invitrogen) at a concentration of 50 μg/ml.
Antibiotic concentrations were determined by susceptibility analysis.
Identification of constraints of the bioluminescent reaction in previously
characterized stable bioluminescent cells
Vectors carrying either the luciferase genes (p2A LuxAB), the substrate
processing genes (p2A LuxCDEfrp), or the full lux cassette (pEF Lux) were
transfected into HEK293/pLuxAB:pLuxCDEfrp cells to determine constraints of
bioluminescent production. Transfections were carried out in six-well tissue
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culture plates (Corning) using Lipofectamine 2000 (Invitrogen). Twenty-four
hours post transfection, cells were washed with PBS and harvested in growth
medium. Equal numbers of transfected cells or untransfected cells (control) in 1
ml volume were plated in triplicate in black 24-well plates for bioluminescent
measurement in the IVIS Lumina imaging system (Perkin-Elmer). Light
production was measured using a 10 min exposure time every 30 min for 16 h
and reported as either total flux values in photons(p)/second(s) or average
radiance values in p/s/cm2/steridian(sr).
Re-transfection of non-bioluminescent luxAB-expressing cells
To determine if an initial chromosomal integration of the luxAB genes was
essential and sufficient for the production of enhanced bioluminescence following
re-transfection of the single lux vector, wild type HEK293 cells (control) and
HEK293 cells stably expressing pIRES LuxAB (HEK293/pIRES LuxAB) were
transfected with pEF Lux or pCMV Lux. Bioluminescent measurements were
carried out as described above.
Development of stable HEK293 cells with enhanced bioluminescence
To test if the enhanced bioluminescent phenotype observed in transient
transfection assays could be stably maintained, selection of stable clones
following successive transfections were attempted. However, direct retransfection and selection was not possible due to the fact that the single lux
vector shared the same Neomycin resistance with current HEK293/pIRES LuxAB
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cells. To overcome this hurdle, a luxAB expression vector harboring an alternate
antibiotic selection marker (Hygromycin) was generated and used to develop a
stable cell line for re-transfection.
Construction of pIRES LuxAB/hygro
The DNA fragment containing the luxA-IRES-luxB sequence was amplified
from pIRES LuxAB by PCR and cloned into a pCR4-TOPO cloning vector
(Invitrogen) to create pCR4-AIB. The AIB fragment was then cut from pCR4-AIB
with EcoRV and NotI and cloned into pcDNA3.1/hygro(+) (Invitrogen) digested
with the same restriction enzymes. The final construct was designated pIRES
LuxAB/hygro.
Selection of cell lines with stable integration of pIRES LuxAB/hygro
Transfection
HEK293 cells were transfected with pIRES LuxAB/hygro to obtain stable cell
lines with stably integrated luxAB sequences and Hygromycin resistance. Cells
were plated in six-well tissue culture plates the day before transfection and
reached approximately 90% confluence at the time of transfection. Vector DNA
purified from overnight E. coli culture was introduced using Lipofectamine 2000
transfection reagent (Invitrogen). Twenty-four hours post-transfection, transfected
cells were harvested and diluted into new 6-well plates in complete growth
medium without antibiotic. Starting the next day, selection of stably transfected
clones was performed by refreshing complete growth medium supplemented with
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50 µg Hygromycin B/ml (Invitrogen) every 3-4 days until all untransfected cells
had died and stably transfected cells had formed visible colonies. At this time,
colonies were isolated by trypsinization and expanded into individual lines for
screening.
Protein extraction and quantification
To extract protein for bioluminescence assays, cells were harvested and
washed twice with PBS. Cell pellets were re-suspended in 1 ml PBS and
subjected to three cycles of freezing in liquid nitrogen for 30 s followed by
thawing at 37°C in a water bath for 5 min. Cell debris was removed by
centrifugation at 14,000 g for 10 min. Supernatant containing the total soluble
protein was retained for bioluminescence assays. Protein concentration was
determined by the BCA protein assay (Pierce) following manufacturer’s
instructions.
Cell lysate-based bioluminescence assays
Bioluminescence assays were performed to determine the activity of the
luciferase (LuxAB) proteins in each clone. Bioluminescence was measured using
an FB14 luminometer (Zylux) with a 1 s integration time and reported as relative
light units (RLU)/mg total protein. To carry out the light assays, 400 μl protein
extract was mixed with 1 μM FMN, 0.1 mM NADPH, 0.1% (w/v) BSA, 0.5 U of
oxidoreductase from Vibrio fischeri (Roche) and 0.001% (w/v) n-decanal (SigmaAldrich) in a total volume of 1 ml. Light signals were detected immediately
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following mixing and normalized to total protein. The clone with the highest
LuxAB protein expression was selected for re-transfection with the single lux
vector.
Re-transfection and selection of stable bioluminescent cell lines
The clone with the highest expression of LuxAB proteins was re-transfected
with pCMV Lux using Lipofectamine 2000 transfection reagent (Invitrogen)
following standard transfection procedures. Successfully transfected cells were
selected based on resistance to Neomycin (Calbiochem) at a concentration of
500 µg/ml. Twenty-four clones were isolated by trypsinization and expanded into
individual lines for bioluminescent measurement using the IVIS Lumina imaging
system (Perkin-Elmer). The clone displaying the highest level of bioluminescence
was designated as HEK293 ECO and chosen for further characterization.
Determination of expression and chromosomal integration of the lux genes
by qRT-PCR and qPCR
Expression of the vector-borne luxC and frp genes as well as the
chromosomally

integrated

non-optimized

luxB

(wtluxB)

gene

following

transfection into wild type or HEK293/pIRES LuxAB cells were analyzed by qRTPCR. Twenty-four h post-transfection, cells were washed with PBS, followed by
RNA extraction using an RNeasy Mini Kit (Qiagen). Reactions were carried out
using the Brilliant II SYBR GREEN One-Step QRT-PCR Master Mix (Agilent) in
25 μl total volume on a PTC-200 Peltier Thermal Cycler (MJ Research). For each
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reaction, a total of 12.5 ng of RNA template were used for reverse transcription.
The following thermal cycles were used for all reactions: 50°C for 30 min, 95°C
for 5 min, and 40 cycles of 30 s at 95°C and 45 s at 60°C. To normalize gene
expression across different samples, expression of the β-actin gene was included
as an internal standard. Primers used for amplifications are listed in Table 7.
Relative gene expression in a given sample and comparison between two
samples was analyzed using the ΔCT and the ΔΔCT method (Livak and Schmittgen
2001), respectively.
Chromosomal integrations of the lux genes were analyzed in three stable
clones displaying varying levels of bioluminescent production. Genomic DNA was
extracted using a Wizard Genomic DNA Prep Kit (Promega). Quantitative PCR
was performed using the Brilliant SYBR Q-PCR system (Agilent) in 25 μl total
volume on a PTC-200 Peltier Thermal Cycler (MJ Research). The following
thermal cycles were used for all reactions: 95°C for 5 min, and 40 cycles of 30 s
at 95°C and 45 s at 60°C. The same primers used in qRT-PCR analysis were
used for amplifications. To determine gene copies, the single-copy ribonuclease
P RNA component H1 RPPH1 gene was included as an internal standard (Table
7).
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Table 7. Primers for qPCR and qRT-PCR analysis of the lux genes.
Primer sequence (5' → 3')

Gene

luxC

frp

wtluxB

β-actin

RPPH1

forward

AGCAAGAAAAGCCTGTGCAT

reverse

CTCGTCGAAGTCCTTCTTGG

forward

CGAGCAGAGACAGACCATCA

Reverse

TGCAGAACACCAGAAACTCG

forward

TAATGGTGTTGTCGGTGCTC

reverse

CGCTATTCGGACAGGATGAT

forward

GCGGGAATCGTGCGTGACATT

reverse

GATGGAGTTGAAGGTAGTTTCGTG

forward

AGCTGAGTGCGTCCTGTCACT

reverse

TCTGGCCCTAGTCTCAGACCTT
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Characterization of the enhanced bioluminescent cells
Minimum detectable population size
HEK293 ECO cells were harvested from 75 cm2 tissue culture flasks and
counted using the Scepter 2.0 handheld automated cell counter (Millipore). Serial
dilutions of cells ranging from ~1 × 106 to ~1 × 103 cells were plated in triplicate in
1 ml of DMEM growth medium in each well of a black 24-well plate. Three wells
were filled with 1 ml of media without cells as negative controls to determine
background. Bioluminescence was evaluated in the IVIS Lumina imaging system
using a 10 min integration time every 30 min for 8 h. Statistical analyses were
performed using the Student’s t tests with a significant p value of 0.05. To
establish the relationship of population size to bioluminescent signal, the average
radiance values in p/s/cm2/sr were correlated to cell numbers using the
Pearson’s linear regression model.
Bioluminescent measurement using a plate reader
To test if the enhanced bioluminescent cells could be detected using a plate
reader, various numbers of cells (ranging from 5 × 102 to 5 × 105 cells) were
plated in triplicate in 200 μl of DMEM growth medium in each well of a black 96well plate. Background noise was assessed using a control of 200 μl of medium
in triplicate wells. Bioluminescence was determined in a Synergy 2 Microplate
Reader (BioTek) using either a 1 s or 10 s integration time every 30 min for 8
hours. To establish the relationship of population size to bioluminescent signal,
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relative light units per second (RLU/s) were correlated to cell numbers using the
Pearson’s linear regression model.

Results
Optimization of bioluminescent production in previously characterized
HEK293/pLuxAB:pLuxCDEfrp cells
A suite of gene supplementation experiments were performed to identify
constraints and potential optimization points of bioluminescent production in
previously characterized HEK293/pLuxAB:pLuxCDEfrp cells. Additional copies of
luxAB or luxCDEfrp were expressed in these cells to determine if the luciferase
levels or the quantities of the substrate processing proteins were limiting light
production. Both supplementations improved signal output but to different extents
(Figure 7A). Increasing the luciferase concentration by expressing extra luxAB
genes

increased

bioluminescence

by

approximately

2-fold,

whereas

supplementation with the luxCDEfrp expression resulted in an approximately 5fold increase in light production (Figure 7B). In an attempt to determine if other
Lux protein-independent endogenous cofactors for aldehyde and FMNH2
synthesis/recycling were limiting factors, up to an approximately 80-fold increase
in light production was observed when the cells were supplemented with
additional copies of all six genes assembled in a single vector (pEF Lux) (Figure
7B). Since such a high level of signal was unexpected, bioluminescent detection
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A

B

C

Figure 7. Optimization of the previously characterized bioluminescent
HEK293/pLuxAB:pLuxCDEfrp cells.
(A) Pseudocolor representations of bioluminescent production from
HEK293/pLuxAB:pLuxCDEfrp cells following transfection with pEF Lux, p2A
LuxAB, or p2A LuxCDEfrp in the IVIS Lumina CCD camera using a 10 min
integration time. (B) Bioluminescent profiles from transfected cells displayed as
fold change over untransfected control over a 16-hour imaging period (n=6,
mean ± standard error). (C) Pseudocolor representations of bioluminescence
detected in HEK293/pLuxAB:pLuxCDEfrp cells transfected with pEF Lux using 1 s
to 30 s integration times.
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originally employed the well-established 10 min integration time for imaging luxbased mammalian cells (Close, Patterson et al. 2010; Close, Hahn et al. 2011).
With an estimated population size of 2.5 - 3 × 106 cells used in this experiment,
10 min exposure caused signal saturation of the CCD camera. For this reason,
decreasing integration times ranging from 10 min to 1 s were applied.
Pseudocolor representations of signal intensity could be conveniently obtained
using as low as a 1 s integration time, although 5 s or longer exposure generated
more consistent images (Figure 7C).
Bioluminescent measurements of singly and doubly transfected cells
Based on the results from direct optimization of the bioluminescent
HEK293/pLuxAB:pLuxCDEfrp cells (Figure 7), it was hypothesized that the initial
chromosomal integration of the partial lux sequences was responsible for the
unexpectedly high increase in light production. This hypothesis was tested by
comparing light production following expression of the single lux vector in wild
type HEK293 cells and HEK293 cells stably expressing the luxAB genes (Figure
8). While the singly transfected cells (wild type cells as host cells) produced a
maximal average radiance of 2.13 (± 0.10) × 103 p/s/cm2/sr, re-transfection of the
HEK293/pIRES LuxAB cells with the same vector lead to a two orders of
magnitude higher light production, with a peak average radiance of 3.10 (± 0.17)
× 105 p/s/cm2/sr. It was further demonstrated that the different bioluminescent
expression levels between singly and doubly transfected cells was not promoter
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Figure 8. Bioluminescent expression following transfection of the lux
polycistronic vector into wild type and luxAB-expressing HEK293
cells.
Wild type (HEK293) and luxAB-expressing (HEK293/pIRES LuxAB) cells
were transfected with pEF Lux or pCMV Lux. Bioluminescence was
determined in equal numbers (1 × 106) of transfected cells (n=3, mean ±
standard error).
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dependent, as the expression of CMV IE-driven lux genes also increased from
8.84 (± 0.22) × 104 p/s/cm2/sr in wild type cells to 2.74 (± 0.03) × 106 p/s/cm2/sr
in luxAB-expressing cells (Figure 8).
Selection of stable cell lines with enhanced bioluminescence
To determine if the enhanced bioluminescent phenotype consistently
observed in transient transfection assays could be stably maintained, antibiotic
resistance-based stable clone selections were attempted. Twenty-four clones
were isolated following transfection of pCMV Lux into HEK293/LuxAB cells and
examined for autonomous bioluminescent production. Twelve of the 24 clones
displayed significantly distinguishable (p < 0.05) bioluminescence over
background, achieving a 50% rate of successful transfection When compared
side-by-side using approximately 1 × 106 cells, seven of the 12 positive clones
produced a peak bioluminescence at least 10-fold higher of the previously
demonstrated HEK293/pLuxAB:pLuxCDEfrp cells (Figure 9). Specifically, the clone
(HEK293 ECO) with the highest level of bioluminescence displayed a maximal
average radiance value of 2.09 (± 0.09) × 105 p/s/cm2/sr, which was the same
order of magnitude as that measured in transient expression assays (Figure 8).
The stability of HEK293 ECO cells was monitored by bioluminescent detection in
the IVIS imaging system after a 2.5-month storage period in liquid nitrogen. The
recovered cells emitted light of 1.93 (± 0.06) x 105 p/s/cm2/sr per one million cells,
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Figure 9. Comparison of bioluminescent production between stable
cell lines generated using the two-step transfection strategy and the
previously characterized bioluminescent cell line.
Bioluminescent production of seven stable cell lines obtained by transfecting
HEK293/pIRES LuxAB/hygro cells with pCMV Lux was compared with that of
the previously characterized, un-optimized HEK293/pLuxAB:pLuxCDEfrp cells
(~ 1 × 106 cells, n=3, mean ± standard error). The cell line (clone 8)
displayed the highest level of light production was designated as HEK293
ECO.
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which was statistically similar to that of the cells before cryopreservation (p >
0.05) (Figure 10).
Expression and chromosomal integration of the lux genes
Quantitative RT-PCR analysis revealed that expression of the lux genes
following transfection was host cell-dependent. Expression of the vector-borne
luxC and frp gene in the luxAB-expressing background increased by ~ 8.5-fold
and ~ 4.6-fold, respectively, compared to their expression in wild type HEK293
cells (Figure 11B). In contrast, expression of the chromosomally integrated
wtluxB gene reduced from ~ 0.7% of β-actin expression in untransfected cells to
~ 0.3% of β-actin expression upon introduction of the single lux vector (Figure
11C).
The contribution of integration position effect on gene expression was
evaluated in three stable clones displaying a gradient of light production. The
copy numbers of the three lux genes tested were determined to be the highest in
the most bioluminescent clone. Insertions of two of the three genes, luxB and frp,
were closely correlated to bioluminescent output, each with an R2 value greater
than 0.90 (Figure 12), suggesting that differences in the inserted copy numbers
were responsible for the majority of light production variations in different stable
lines.
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Figure 10. Comparison of bioluminescent production of HEK293 ECO
cells before and after cryopreservation.
Bioluminescent production of 1 × 106 HEK293 ECO cells were assayed before
cryopreservation and after recovery from a 2.5-month storage period in liquid
nitrogen (n=3, mean ± standard error).

93

A

B

C

Figure 11. Differential transfection methods result in disparate gene
expression levels.
(A) Schematic representation of differential transfection methods. pEF Lux
was transfected into wild type (HEK293) or luxAB-expressing (HEK293/pIRES
LuxAB) cells (chr: chromosomal integrated; homologous regions were
indicated by dash lines)). (B) Expression of the plasmid-borne luxC and frp
genes following pEF Lux transfection into HEK293 or HEK293/pIRES LuxAB
cells was determined by qRT-PCR (n=9). (C) Expression of the
chromosomally integrated wtluxB gene in HEK293/pIRES LuxAB cells was
examined before and after transfection with pEF Lux (n=6).
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Figure 12. Correlation between lux gene copy numbers and
bioluminescent production.
The correlation between lux gene copy numbers and bioluminescent
production were determined in three stable bioluminescent cell lines
obtained by transfecting HEK293/pIRES LuxAB/hygro cells with pCMV
Lux. Results represent RPPH1-normalized gene copy numbers
determined by qPCR (n=3) and bioluminescence from 5 × 104 cells (n=3).
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Bioluminescent profiles of the enhanced HEK293 ECO bioluminescent cells
Before the newly developed bioluminescent cell line can be used as a
functional optical reporter, its bioluminescent profile under different detection
conditions must be characterized. The enhanced bioluminescent ECO cells were
assayed over a dynamic population range to determine minimum detectable cell
number in the IVIS imaging system using a 10 min integration time in a 24 well
plate format (Figure 13A). Compared to the previously described bioluminescent
HEK293/pLuxAB:pLuxCDEfrp cells that could not be reliably detectable under ~ 1.5
× 104 cells using the same imaging conditions (Close, Hahn et al. 2011), a
minimum of ~ 1 × 103 ECO cells were significantly distinguishable from
background (p = 0.0004) (Figure 13B).
One limitation of the previously characterized cells was that their detection
was limited to the sensitive yet relatively expensive CCD camera-based system
due to their low signal intensity. With the improvement of bioluminescent
production in ECO cells, it remained to be determined if the newly developed
cells were amenable to other conventional luminescent detecting instruments.
The bioluminescent production of ECO cells was surveyed in a 96-well plate
format using a photomultiplier tube (PMT)-based Synergy 2 microplate reader.
Unlike the increase of signal output in the first few hours detected by in the IVIS,
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Figure 13. Minimum detectable population size of the enhanced
bioluminescent HEK293 ECO cells.
The minimum detectable population size of HEK293 ECO cells were
determined by (A) plating a range of cell concentrations (K: thousand, M:
million) in equal volumes of media in triplicate in a black 24-well plate. (B)
Approximately 1 × 103 cells could be significantly distinguished from medium
background ( p < 0.05) (n=3, mean ± standard error).
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the Synergy detected signal remained relatively constant over 8 hours (Figure
14A). The minimal detectable population size was determined to be
approximately 5 × 103 cells in 96 well plates. Because of the lower sensitivity of
the plate reader, the same population size produced a lesser signal to noise ratio
compared to the IVIS system (Table 8).
Despite the intrinsic difference in signal detection mechanisms between the
VIS Lumina and Synergy 2 instruments and plating format, the bioluminescent
output from HEK293 ECO cells remained linearly correlated to the numbers of
cells present in the population (R2 > 0.99), regardless of exposure time (Figure
14B and 14C).

Discussion
The recent development of the lux system into a functional reporter in
mammalian cells provides a novel and attractive tool for bioluminescent imaging.
It allows for continuous and non-invasive monitoring of the same target over time
both in vitro from cell culture and in vivo using living small animal models without
any substrate being added exogenously (Close, Hahn et al. 2011). Despite this
appealing feature, bioluminescent output using current lux-expressing strategies
is much lower than that of the traditional substrate-requiring firefly luciferase
system, limiting wider applications of this system.
As a first step of optimization, we assessed the constraints for bioluminescent
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Figure 14. Comparison of bioluminescent detection of the HEK293 ECO
cells using the IVIS imaging system and the Synergy microplate reader.
The bioluminescent profiles of the HEK293 ECO cells were surveyed in the
IVIS Lumina imaging CCD camera and the Synergy 2 microplate reader using
a 24- or 96- well plate format, respectively (n=3, mean ± standard error).
Although these two detection schemes displayed varying dynamics over time,
exemplified by (A) bioluminescent detection from of approximately 5 × 105
HEK293 ECO cells plated in each well of a 24 well plate in 1 ml medium (IVIS
detection) or in each well of a 96 well plate in 200 µl medium (Synergy
detection), tight correlation between signal and population size were obtained
under both conditions ((B) IVIS measurements and (C) Synergy
measurements).
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Table 8. Comparison of bioluminescent detection from HEK293 ECO cells using
the IVIS Lumina imaging system and the Synergy 2 microplate reader.

Population
Size
(Cells/Well)
5 × 102

IVIS
(24-well plate, 10 min exposure)
(n=3)
Fold
Total Flux (p/s)
Change
(± standard error)
(± standard
error)
n.d.

Microplate Reader
(96-well plate, 1 s
exposure/well) (n=3)
Fold
RLU/s
Change
(± standard
(± standard
error)
error)
7.0 ( ± 1.0)*

0.9 ( ± 0.2)

1 × 103

1.95 ( ± 0.06) × 104

1.5 ( ± 0.1)

8.0 ( ± 1.0)*

1.0 ( ± 0.3)

5 × 103

4.62 ( ± 0.14) × 104

3.6 ( ± 0.1)

14.3 ( ±0.9)

1.9 ( ± 0.4)

1 × 104

7.81 ( ± 0.16) × 104

6.1 ( ± 0.2)

17.3 ( ± 0.3)

2.3 ( ± 0.5)

5 × 104

3.21 ( ± 0.06) × 105

25.0 ( ± 0.7)

52.0 ( ± 2.1)

6.8 ( ± 1.4)

1 × 105

6.12 ( ± 0.04) × 105

47.6 ( ± 1.0)

90.3 ( ± 6.2)

11.8 ( ± 2.5)

5 × 105

2.60 ( ± 0.05) × 106

201.6 ( ± 5.4)

403.0 ( ± 14.9)

52.6 ( ± 10.7)

1 × 106

4.59 ( ± 0.02) × 106

356.9 ( ± 7.2)

n.d. - not determined.
* - not significantly distinguishable from background (p > 0.05).
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n.d.

production in the previously described HEK293/pLuxAB:pLuxCDEfrp cells. The
chemical reaction of the lux-based bioluminescence system is a typical enzymesubstrate reaction (Meighen 1991). The rate of this reaction, reflected by
bioluminescent flux (photons/second), is dependent on the concentrations of the
luciferase enzyme as well as the availabilities of the aldehyde and FMNH2
substrates present in the host cells. While the luciferase concentration is directly
related to the expression of the luxAB genes, synthesis and recycling of the
aldehyde substrate and FMNH2 are dependent not only upon the concentrations
of the LuxCDE and Frp proteins, but also on the availability of other endogenous
substrates and co-factors present in the host cell (such as NADPH). In the
previously characterized cells, the lux cassette is split into two expression vectors
with a total of three promoters for the regulation of gene expression. The
uncoupled expression of the luciferase genes and the substrate processing
genes may result in an unbalanced enzyme/substrate ratio that is not optimal for
the reaction. Previous in vitro substrate supplementation studies imply that
aldehyde and FMNH2 are both limiting factors for light production (Close,
Patterson et al. 2010). In this study, gene supplementations showed consistent
results that introducing additional copies of the luxCDEfrp genes increased light
production by a larger fold compared to luxAB addition (5- vs. 2- fold). However,
the relative fold change by in vivo gene addition is not as prominent as that
following direct substrate amendment. There are three possible explanations: 1)
even with the additional copies of genes introduced in this manner, protein
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synthesis is still insufficient to supply the same level of substrate that is
supplemented in vitro, 2) substrate synthesis is limited by other host cellular
factors, and 3) increased level of substrate becomes cytotoxic to the host cells
(Hollis, Lagido et al. 2001). With the subsequent finding that a substantial
increase (~ 80 fold) in bioluminescence production is possible if all six genes are
added at the same time (Figure 7), it becomes clear that availability of host cofactors and increased in vivo aldehyde synthesis are not major limiting factors for
high level light production.
A surprising discovery from the gene supplementation study is that
expressing the single lux vector in HEK293/pLuxAB:pLuxCDEfrp cells produces
significantly higher bioluminescence (peak average radiance in the order of 105
p/s/cm2/sr) than that obtained by expressing the same vector in wild type cells
(peak average radiance in the range of 103 p/s/cm2/sr). The non-additive,
synergistic increase in light production leads to the hypothesis that the initial
chromosomal insertion of the lux genes is capable of promoting gene expression
in the second transfection event, probably through homologous recombinationmediated gene integration. This hypothesis was investigated in a unique type of
cells expressing the stably integrated luxA-wtluxB transcriptional fusion (Figure
11A). In these cells, the chromosomal copy of the luxA gene is a formerly
optimized sequence and shares 85% homology to the more recently optimized
luxA sequence carried on the single lux vector (Table 6, Chapter II). The
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integrated luxB is an un-optimized wild type sequence (wtluxB) derived from its
bacterial host P. luminescens, and has 75% identity to the codon-optimized luxB
sequence present in the lux vector. Despite the homology between wtluxB and
codon-optimized luxB sequence, it was possible to design specific primers to
only amplify the chromosomally integrated wtluxB but not the vector-borne luxB
sequence. Because transcription of wtluxB is coupled to that of the upstream
luxA gene, homologous recombination between the lux vector and the
chromosomal luxA sequence, if it occurs, would disrupt the transcription of
wtluxB from the promoter and reduce its expression. Therefore, cells expressing
this construct allow us to study the effect of homology between the chromosomal
and vector-borne luxA sequences on the highly enhanced bioluminescent
production, as well as to use the wtluxB expression as a marker for homologous
recombination.
As expected, expressing the single lux vector pEF Lux in this genetic
background produced similarly high levels of light, with a peak average radiance
of ~ 3 × 105 p/s/cm2/sr (Figure 8), supporting the hypothesis that initial genomic
integration of a partial lux cassette is sufficient to promote high level
bioluminescent expression. Furthermore, the luxC and frp transcripts were found
to be approximately 8.5-fold and 4.6-fold higher, respectively, when expressed in
these cells compared to wild type controls (Figure 11B). The higher mRNA level
could be the result of increased transgene integration, augmented transcription
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per incorporated transgene copy, or a combination of both. While experimental
assessments are still required to determine whether transcription is increased on
a per copy basis, there is evidence presented in the literature as well as in this
study supporting the idea that the pre-integrated luxA sequence may improve
targeted integration of the secondly introduced lux cassette.
Foreign DNA is integrated into the cell genome using two antagonistic DNA
double strand break (DSB) repair pathways, non-homologous end joining (NHEJ)
or homologous recombination (Grandjean, Girod et al. 2011). Integrations of
transfected DNA rely on the capture DSBs on random genomic sites (for NHEJmediated insertion) or on chromosomal loci that are homologous to the foreign
DNA molecules (for homology-mediated integration). Because DSBs occur at
very low frequency, stable transgene integrations are rare events. However,
increasing the homology between transfected nucleotides and the recipient
genome can improve integration efficiency to a certain extent. It has been
reported previously that recombination between the newly introduced DNA and
the homologous region in the host genome is able to mediate highly frequent site
specific integration in mammalian cells (Thomas, Folger et al. 1986; Deng and
Capecchi 1992; Grandjean, Girod et al. 2011). In rice, there has been evidence
showing that during direct plasmid DNA transfer, the initial insertion sites attract
successively transferred DNA to integrate at the same locus (Kohli, Leech et al.
1998). In this study, the pre-integrated luxA sequence establishes a homologous
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region in the chromosome, which may act as a hot spot for integration of the
latterly introduced lux cassette. Additionally, transcription of the wtluxB gene is
found to be reduced by ~ 60% following introduction of the lux vector (Figure
11C), suggesting possible transcriptional interruption from its promoter or gene
disruption, either of which could be a result of recombination at or near the
upstream luxA sequence.
The two-step transfection strategy developed here is also associated with a
relatively high efficiency for transgene expression, with 50% of cell lines selected
based on antibiotic resistance displaying successful bioluminescent production.
This level of efficiency is superior to that obtained from single transfection of wild
type cells (less than 10%). Stable heterologous protein expression requires the
full transgene construct, including the promoter, the protein coding region, and
other essential mRNA processing signals, to be integrated into the cell genome
as an intact expression unit. Isolation of cells with stable transgene expression,
however, is usually initiated by selecting antibiotic-resistant phenotypes
conferred by the co-transfected resistance marker. This often results in false
positive clones that express only the resistance gene but not desired transgenes,
probably due to no integration or integration of only partial transgene expression
units. Screening for light-emitting phenotypes within the resistant population is
further complicated by the fact that bioluminescent production requires proper
integration and expression of six genes (luxCDABEfrp), yielding a relatively high
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false positive rate in the case of random integration following transfection into
wild type cells. Alternatively, in homology-mediated integration, because
integration is less random and more targeted, higher integration of an intact
transgene can be obtained (Deng and Capecchi 1992; Liu, Chan et al. 2010).
Together with the homology between the pre-integrated luxA and the newly
introduced lux cassette, the higher efficiency observed in doubly transfected cells
also suggests that the synergistic bioluminescent expression might be a
homologous recombination-mediated effect.
In random, non-targeted insertion, transgene expression is often varied by
integration sites due to highly dynamic local genetic architecture of the inserted
locus (Kwaks and Otte 2006). In site-specific targeting, on the other hand, the
position effect is obviated and transgene expression is mainly copy-number
dependent. In this study, insertions of the luxB and frp genes were closely
correlated with bioluminescent production in stable cell lines developed by the
two-step transfection strategy (Figure 12), suggesting that differences in the
inserted copy number were responsible for the majority of light production
variations in different stable lines.
The stable luxAB-expressing cells used as the recipient for the second
transfection are those that have undergone selection for optimal luciferase
expression. Therefore, it is possible that the luxAB sequence has been integrated
into a region that favors high level gene expression, or into multiple sites. If this

106

stays true, the secondarily introduced lux vector will be targeted into this region(s)
through the proposed homologous recombination-mediated integration, which
also partially explains the improved bioluminescent production following
transfection into these cells.
It is important to note that homologous recombination-mediated gene
integration is a rare event, especially in non-embryotic stem cells. Although
evidence present in this study and other literature both implies that homology
between the pre-established partial lux sequence and the newly introduced full
lux cassette may target more frequent insertion of the vector sequence into the
cell genome, other possibilities such as increased random integration into the
host genome cannot be excluded and the detailed mechanism of the synergistic
lux expression and exact locus for integrations will still require further
experimental assessment.
From a practical point of view, the newly optimized bioluminescent cells
developed here through the two-step transfection strategy have important
advantages over their previously validated counterparts. First of all, the improved
cells can be detected at a more dynamic population range compared to the unoptimized cells, with an ~ 15-fold lower minimum detectable population size.
While the un-optimized cells are limited to applications that use larger cell
populations (≥ 1.5 × 104 cells), a minimum of ~ 1 × 103 of the enhanced
bioluminescent cells are detectable (Figure 13), and thus are suitable for studies
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that require relatively small cell populations, such as drug susceptibility testing
and long term cell growth analysis. The un-optimized cells have been reported to
require a minimum of ~ 2.5 × 104 cells for whole animal in vivo imaging following
subcutaneous injection into a mouse model (Close, Hahn et al. 2011). Although
the minimum population size of the optimized cells remains to be determined in
the mouse model, it is predicted based on in vitro cell culture detection that less
cells will be detectable. Furthermore, due to photon scattering and absorption by
endogenous chromophores (Rice, Cable et al. 2001), the un-optimized cells are
not ideal for imaging from deep tissue. With two orders of magnitude
improvement of bioluminescent production, the enhanced cells should overcome
this limitation and provide an alternative, substrate-free tool for deep tissue
imaging applications that traditionally employ the FLuc reporter. However, it is
also important to note that, even though the signal intensity has been upgraded
significantly in the newly optimized lux-expressing cells, it is still not as strong as
that produced from the FLuc reporter cells (Kim, Urban et al. 2010; Close, Hahn
et al. 2011). While the newly optimized lux system will not completely replace the
FLuc system, it certainly provides a substrate-free alternative for some
applications if the desired population size is covered by the dynamic ranges of
the lux system.
Another advantage associated with the enhanced bioluminescent cells is that
they are suitable for multiple types of detection. The un-optimized cells are
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limited to detection by highly sensitive but more expensive instruments such as
the CCD camera-based IVIS imaging system, but are not detectable using
relatively less sensitive PMT detection, due to its low signal intensity. In contrast,
the newly optimized cells are readily detectable using less expensive instruments
such as the Synergy microplate reader, thus facilitating higher-throughput
applications.
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CHAPTER IV
Towards lux-Based Autonomous Biosensing in Human Cell
Lines
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Introduction
Despite its extensive use in bacterial whole-cell bioreporters for detection of a
diverse range of compounds and conditions (reviewed in Xu, Close et al. (2012)),
the application of bacterial bioluminescence (lux) in eukaryotic organisms is
extremely limited, due largely to the obstacles preventing successful expression
of the essential lux genes at a functional level for bioluminescence production in
the eukaryotic cellular background. It was not until 20 years after the first
demonstration of exogenous lux expression and acquired bioluminescent
phenotype in E. coli (Engebrecht, Nealson et al. 1983) that the lux cassette had
finally been expressed efficiently in lower eukaryotic organisms. By expressing
the luxCDABE and frp genes through a combination of separation of genes into
two vectors, use of bi-directional expression vectors, and insertion of IRES
elements to mimic polycistronic translation, Gupta and colleagues successfully
created autonomously luminescent S. cerevisiae for the first time (Gupta,
Patterson et al. 2003). This breakthrough quickly progressed into the generation
of autonomously bioluminescent eukaryotic reporters for rapid detection of
estrogenic and androgenic compounds (Sanseverino, Gupta et al. 2005; Eldridge,
Sanseverino et al. 2007).
Estrogenic and androgenic compounds represent a unique family of chemical
targets that cannot be screened exhaustively using analytical chemical methods,
due to the fact that they are defined not by their chemical structures but by their
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physiological impacts on living organisms. According to the recent Scientific
Statement by The Endocrine Society (Diamanti-Kandarakis, Bourguignon et al.
2009), endocrine disrupting chemicals (EDCs) are “substances in our
environment, food, and consumer products that interfere with hormone
biosynthesis, metabolism, or action resulting in a deviation from normal
homeostatic control or reproduction.” There has been a rich body of scientific
literature providing evidence on the potential effects of EDCs on reproductive,
developmental, and metabolic disorders inclusive of breast, ovarian, testicular,
and prostate cancers, early onset of puberty, genital tract abnormalities, reduced
sperm counts, and various other health related problems in both humans and
wildlife (Diamanti-Kandarakis, Bourguignon et al. 2009). Due to these public
health concerns, the U.S. Environmental Protection Agency (EPA) has been
required by law (the 1996 amendments to the Safe Drinking Water Act and the
1996 Food Quality Protection Act) to develop a program to screen and test
chemicals used in a variety of industries such as pesticides and personal care
products for their endocrine disrupting activities. With an estimated number of ~
87,000 chemicals to be screened, bioassays for rapid and high-throughput
detections are highly desired.
Detection of endocrine disrupting compounds is not feasible using traditional
bacterial bioreporters due to their lack of essential receptors and signaling
components with which these compounds interact. Even with their eukaryotic
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genetic and cellular background, the aforementioned bioluminescent yeast
estrogen and androgen bioreporters still require recombinant expression of the
human estrogen and androgen receptor, respectively, for proper function.
Although yeast-based assays offer the advantage of rapid detection, they can
also produce false results regarding human effects, due to factors such as the
difference in chemical uptake between the yeast cell wall and the mammalian
cellular membrane, varying receptor levels and metabolic capabilities, and in
some cases, the inability to differentiate agonists and antagonists (Zacharewski
1997).
Human cell lines, on the other hand, can serve as a native platform for
bioreporter development because they directly represent human bioavailability
and toxicity. Most of the current estrogen bioreporters using human cell lines as
hosts utilize firefly luciferase as the reporting element. These reporters are
created by transcriptionally fusing reporter gene expression to one or more
estrogen response elements (EREs), which are unique cis-acting regulatory DNA
elements recognized by the DNA binding domain of the estrogen receptor. Upon
binding to estrogen/estrogenic chemicals, the ligand-receptor complex forms a
homodimer that interacts with the EREs to recruit transcriptional factors that
regulate the expression of the associated genes. Several Luc-based in vitro
estrogen bioreporters have been developed in this manner using the human
breast cancer cell lines T-47D and MCF-7, as they naturally express the estrogen
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receptors required for reporter gene activation (Balaguer, Francois et al. 1999;
Legler, van den Brink et al. 1999; Wilson, Bobseine et al. 2004). These
bioreporters are advantageous over their yeast counterparts in regard to their
uptake of chemicals, receptor concentrations, signaling pathways, and their
ability to distinguish between agonists and antagonists (O'Connor, Cook et al.
2002). However, these cells do not metabolize most of the EDCs, and thus are
unsuitable for detection of compounds that are not estrogenic until being
metabolized in vivo (for instance, by the liver) (Soto, Maffini et al. 2006). Although
a transgenic mouse model can be developed for in vivo detection (Ciana, Di
Luccio et al. 2001), it cannot be done in a non-invasive manner because of the
requirement of exogenous substrate addition for producing a detectable signal.
The limitations posed by the substrate-requiring Luc system could potentially
be overcome by using the lux system that has recently been adapted for use in
the mammalian cellular background. In addition, the substrate-free nature of the
lux system permits continuous real-time monitoring of cellular functions in a noninvasive manner. Therefore, the autonomous bioluminescent expression from a
mammalian cell line could be used to directly detect the human bioavailability of
targets of interests. Because no cell destruction or substrate amendment is
required, it also has the potential to be developed into an in vivo model. To
advance its broader applications, this chapter describes the preliminary steps of
developing the lux system towards a fully autonomous reporter for use in human
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cell lines.

Materials and Methods
Strain growth and maintenance
Human breast carcinoma T-47D cells were regularly maintained in phenol-red
free RPMI-1640 medium (Hyclone) supplemented with 10% FBS, 0.01 mM nonessential amino acids, 1X antibiotic-antimyotic and 0.01 mM sodium pyruvate.
Cells were cultured at 37°C in a 5% CO2 environment with medium being
refreshed every 2 - 3 days. Cells were passaged regularly upon reaching 80%
confluence. For estrogen treatment assays, assay medium was modified from
growth medium by substituting 10% charcoal/dextran-treated FBS (CD-FBS)
(Hyclone). Neomycin at the concentration of 500 µg/ml was used for selection
and maintenance of stably transfected cells.
HEK293 Tet-On cells expressing the tetracycline-regulated transactivator
were purchased from Clontech and maintained in Dulbecco's Modified Eagle
Medium (DMEM) supplemented with 100 μg Neomycin/ml, 10% FBS, 0.01 mM
non-essential amino acids, 1X antibiotic-antimyotic and 0.01 mM sodium
pyruvate. For doxycycline induction assays, assay medium was modified from
growth medium by 10% Tet System Approved FBS (Clontech).
Escherichia coli TOP10 cells (Invitrogen) were used to host and propagate
plasmids used in this study. E. coli cells were routinely grown in Luria Bertani (LB)
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broth at 37°C with 200 rpm continuous shaking. Kanamycin or ampicillin was
used at a final concentration of 50 or 100 µg/ml, respectively, for selection and
maintenance of successfully transformed E. coli cells.
Vector construction
To construct a vector in which expression of luxAB genes was regulated by
an estrogen responsive promoter, a double-stranded DNA fragment containing
three tandem copies of the estrogen response element (ERE) and the
adenovirus E1B minimal TATA promoter (GGGTATATAAT) was synthesized by
annealing two complementary synthetic oligonucleotides (ERE3-TATA fwd and
rev, Table 9) that were designed to include a BglII overhang on the 5' end and an
XmaI overhang on the 3’ end to facilitate downstream cloning. The annealing
reaction was carried out at 70°C for 10 min with 1X Taq polymerase buffer. The
resulting double-stranded DNA was purified and cloned into the BglII and XmaI
cloning sites in pd2EGFP-1 (Clontech) to generate pERE3-TATA-d2EGFP.
To construct pERE3-TATA-LuxAB, the luxA-IRES-luxB sequence was PCR
amplified from pIRES-LuxAB using primers AIB fwd and rev (Table 9) with
introduced 5’ end AgeI restriction site and cloned into a pCR4-TOPO vector
(Invitrogen) to generate pCR4LuxAB. The d2EGFP protein coding region was
then removed from pERE3-TATA-d2EGFP by AgeI and NotI double restriction
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Table 9. ERE sequences and primers used for vector construction.
Oligonucleotide

Sequence (5' → 3')

ERE3-TATA fwd

gatctAGGTCACTGTGACCTCTCGAGGTCACTGTGACCTCTCGAG
GTCACTGTGACCTGCGATCGCGGGTATATAATc

ERE3-TATA rev

ccgggATTATATACCCGCGATCGCAGGTCACAGTGACCTCGAGA
GGTCACAGTGACCTCGAGAGGTCACAGTGACCTa

AIB fwd

ACCGGTCGAGAATTCGCCCTTGCTA

AIB rev

CTGAGCTCTGGCCCAGTC

underscored - estrogen response element (ERE).
shaded bold - adenovirus E1B minimal TATA promoter.
lower case italic - partial restriction sites used for cloning.
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digest and replaced by the luxA-IRES-luxB sequence, which was cleaved from
pCR4LuxAB with the same restriction enzymes and purified from agarose gel
using the Qiaquick Gel Extraction Kit (Qiagen). The successfully ligated plasmid
was confirmed by sequencing and designated as pERE3-TATA LuxAB.
The ERE3-TATA promoter was then removed from pERE3-TATA LuxAB using
MluI and SalI and cloned into similarly digested pCMV Lux to replace the CMV IE
promoter. The final construct was named pERE3-TATA Lux. A modified version
of this vector was created by replacing the TATA box promoter with a CMV IE
minimal (CMVm) promoter cloned from pIRES LuxAB to create pERE3-CMVm
Lux.
To create a reporter construct for tetracycline response element (TRE)regulated polycistronic expression of the luxCDABEfrp genes, the TRE and its
associated minimal CMV promoter were removed from the pTRE-Tight-BI vector
(Clontech) using Acc65I and XbaI and cloned into similarly digested pERE3TATA Lux to replace the ERE3-TATA promoter (all vectors used in this study are
listed in Table 4).
Transfection of mammalian cells
Transfections were carried out in 6-well tissue culture plates (Corning). The
day prior to transfection, cells were plated at a density of 5 × 105 cells/well (for
HEK293 Tet-On cells) or 7.5 × 105 cells/well (for T-47D cells). Vector DNA
purified from overnight E. coli culture using PureYield Plasmid Purification
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System (Promega) was introduced into the cells using Lipofectamine 2000
transfection reagent (Invitrogen) following the manufacturer’s instructions.
Transfected cells were either assayed twenty-four hours post transfection, or
subjected to stable transfectant selection as described below.
Screening for stably transfected reporter cell lines
T-47D cells transfected with pCMV Lux or pERE3-TATA LuxAB were
subjected to stable transfectant selection. Twenty-four hours post-transfection,
transfected cells were harvested and diluted into new six-well plates in growth
medium without antibiotic selection. Starting the next day, selection of stably
transfected clones was performed by refreshing with selective medium containing
500 µg Neomycin/ml every 2 - 3 days until all untransfected cells had died and
stably transfected cells had formed visible colonies. The colonies were then
removed by trypsinization and expanded into individual lines in growth medium
supplemented with Neomycin at a 500 µg/ml concentration.
To screen for autonomous bioluminescence following transfection with pCMV
Lux, each isolated cell line was grown in individual 25 cm2 tissue culture flasks
and harvested for imaging upon reaching ~80% confluence. Cells were collected
in 1 ml of RPMI-1640 growth medium and plated in each well of a black 24-well
plate. Bioluminescent measurements were carried out using the IVIS Lumina
Imaging System (Perkin-Elmer) with a 10 min integration time every 30 min for
24 h. The cell line displaying the highest bioluminescent production was
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designated T-47D/Lux and used in further analysis.
To screen stable transfectants for estrogen-regulated LuxAB expression
following transfection with pERE3-TATA LuxAB, each isolated cell line was
propagated in 25 cm2 tissue culture flasks with RPMI-1640 assay medium
(containing 10% CD-FBS). Upon reaching 80% confluence, cells were split into
multiple 25 cm2 tissue culture flasks containing equal number of cells per flask.
Upon reaching 80% confluence 17β-estradiol (E2) (Sigma-Aldrich) or HPLCgrade ethanol was added at a final concentration of 10 nM or 0.1% (v/v),
respectively. Twenty-four hours post treatment, total protein was extracted and
assayed for bioluminescence as described below. Positive cell lines were further
tested for 24-hour induction with various concentrations of E2 (5 pM to 10 nM)
using the same assay.
Determination

of

LuxAB

activity

using

the

cell

lysate-based

bioluminescence assay
Expression of LuxAB proteins in transiently transfected cells or stable
transfectants was determined using the cell lysate-based bioluminescence
assays. For transient expression, T-47D cells transfected with pERE3-TATA
LuxAB were harvested 24 hours post transfection and treated with 10 nM E2 for 6,
12, or 24 hours before being lysed for bioluminescence assay. Stable
transfectants were assayed after 24 hours of E2 treatment as described above.
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Protein extraction and quantification
To extract protein for bioluminescence assays, cells were harvested and
washed twice with sterile phosphate buffered saline (PBS). Cell pellets were resuspended in 1 ml PBS and subjected to three cycles of freezing in liquid
nitrogen for 30 s followed by thawing at 37°C in a water bath for 5 min. Cell
debris was removed by centrifugation at 14,000 g for 10 min. Supernatant
containing the total soluble protein was retained for bioluminescence assays.
Protein concentration was determined by the BCA protein assay (Pierce)
following the manufacturer’s instructions.
Cell lysate-based bioluminescence assays
Cell lysate-based bioluminescence assays were performed to determine the
activity of LuxAB proteins in cell extracts. Bioluminescence was measured using
an FB14 luminometer (Zylux) with a 1 s integration time and reported as relative
light units (RLU)/mg total protein. To carry out the light assays, 400 μl protein
extract was mixed with 1 μM FMN, 0.1 mM NADPH, 0.1% (w/v) BSA, 0.5 U of
oxidoreductase from V. fischeri (Roche) and 0.001% (w/v) n-decanal (SigmaAldrich) in a total volume of 1 ml. Light signals were detected immediately
following mixing and normalized to total protein.
Correlating population size with bioluminescence in T-47D/Lux cells
Actively growing T-47D/Lux cells were trypsinized and harvested from 75 cm2
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tissue culture flasks and counted using a hemacytometer. Groups of either 2.5 ×
105, 1 × 105, 5 × 104, 2.5 × 104, 1 × 104, 5 × 103, or 2.5 × 103 cells were plated in
triplicate in 1 ml of phenol red-free RPMI-1640 complete growth medium in each
well of a clear-bottom, tissue culture-treated, black 24-well plate. A negative
control for monitoring background was performed in triplicate wells containing 1
ml of medium without cells. Bioluminescence was determined in the IVIS Lumina
imaging system using a 10 min integration time every 30 min for 16 h. Statistical
analysis was performed using Student’s t tests with a significant p value of 0.05.
To establish the relationship between population size and bioluminescent signal,
the total flux values in p/s were correlated to cell numbers using the Pearson’s
linear regression model.
Bioluminescent T-47D/Lux estrogen assay
The bioluminescent T-47D estrogen screening assay was carried out in clearbottom, tissue culture treated, black 24-well plates. Approximately 1 × 104 T47D/Lux cells were seeded into each well in 1 ml growth medium and were
allowed to attach for 24 h. Before addition of E2, medium was refreshed with 1 ml
CD-FBS containing assay medium. E2 (using HPLC grade ethanol as the solvent)
was added at final concentrations of 0 pM (control), 0.1 pM, 1 pM, 10 pM, 100
pM, 1 nM, 10 nM, or 100 nM in triplicate wells. Solvent concentration remained
constant at 0.1% (v/v) across all wells. Bioluminescent measurements were
obtained using the IVIS Lumina imaging system with a 10 min integration time
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every 24 h for 6 days. Cells were incubated at 37°C in a 5% CO2 environment
between measurements.
Bioluminescent measurement of ERE-lux reporter cells in response to
estrogen
Estrogen-induced bioluminescent expression of pERE3-TATA Lux and
pERE3-CMVm Lux was examined in T-47D cells in transient expression assays.
Transfections were carried out in assay medium (RPMI containing 10% CD-FBS)
as described previously. Twenty-four h post transfection, cells were washed with
sterile PBS and counted using a hemocytometer. Approximately 1 × 106 cells
were plated in each well in 1 ml assay medium in a black 24-well plate. E2 was
dosed at final concentrations of 0 (control), 1 or 10 nM with a 0.1% (v/v) solvent
(ethanol)

concentration.

Bioluminescent

measurements

were

performed

immediately after estrogen amendment using the IVIS Lumina imaging system
using a 10 min integration time every 30 min for 24 hours.
Bioluminescent measurement of Tet-lux reporter cells in response to
doxycycline
Doxycycline-induced bioluminescent expression of pTet Lux was examined in
HEK293 Tet-On cells in transient expression assays. Transfections were carried
out in assay medium (DMEM containing 10% Tet System Approved FBS) as
described previously. Twenty-four h post transfection, cells were washed with
sterile PBS and counted using the Scepter 2.0 handheld automated cell counter
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(Millipore). Approximately 1 × 106 cells were plated in each well in 1 ml assay
medium in a black 24-well plate. Doxycycline was added at final concentrations
of 0 (control) or 100 ng/ml in replicate wells. Bioluminescent measurements were
performed immediately after doxycycline induction using the IVIS Lumina
imaging system using a 10 min integration time every 30 min for 19 h.
Quantitative RT-PCR analysis of lux gene expression
Expression of the lux genes was analyzed by qRT-PCR. The expression of
the luxC gene was evaluated in T-47D cells transiently expressing the pERE3CMVm Lux reporter construct after 24-hour exposure to 0 or 1 nM E2, as well as
in constitutively bioluminescent T-47D cells stably expressing pCMV Lux. The
expression of the luxC, luxB, and frp genes was determined in HEK293 Tet-On
cells transiently expressing the pTet Lux reporter construct after 19-hour
exposure to 0 or 100 ng doxycycline/ml.
Total RNA was extracted using an RNeasy Mini Kit (Qiagen). For RNA
extracted from transiently transfected cells, an additional step of DNase I
treatment using a DNA-Free RNA kit (ZymoResearch) was performed to remove
co-extracted plasmid DNA. qRT-PCR reactions were carried out using the
Brilliant II SYBR GREEN One-Step QRT-PCR Master Mix (Agilent) in 25 μl total
volumes on a PTC-200 Peltier Thermal Cycler (MJ Research). For each reaction,
a total of 12.5 ng of RNA template were used for reverse transcription. The
following thermal cycles were used for all reactions: 50°C for 30 min, 95°C for 5
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min, and 40 cycles of 30 s at 95°C and 45 s at 60°C. To normalize gene
expression across different samples, expression of the β-actin gene was included
as an internal standard. Relative gene expression in a given sample and
comparison between two samples was analyzed using the ΔCT and the

ΔΔCT

method (Livak and Schmittgen 2001), respectively.

Results
Development of a constitutively bioluminescent T-47D/Lux cell line and its
potential application in an estrogen screening assay
Selection of stable autonomously bioluminescent cell lines
Thirty-five stable cell lines were established following neomycin selection of
T-47D cells transfected with the pCMV Lux expression vector. Each of these
lines was interrogated for autonomous bioluminescent production using the IVIS
Lumina imaging system. Despite growing efficiently under selective media
conditions, only five lines displayed significantly distinguishable light output
compared to background. Due to possible integration position effects and
variations in inserted copy numbers, these cell lines exhibited varying light output
(ranging from 104 to 106 p/s for one million cells). The cell line that showed the
highest level of bioluminescent production was designated as T-47D/Lux and
chosen for further investigation.
The bioluminescent profile of the T-47D/Lux cells was investigated to
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determine the optimal time frame for bioluminescence detection. Since it has
been shown previously that transiently transfection T-47D cells maintained
relatively stable bioluminescence production for 20 h in the imaging system
(Chapter II), long term monitoring of approximately 1 × 106 stable T-47D/Lux cells
was attempted for 96 h to determine the maximal time frame for continuous
imaging (Figure 15A). As observed in the transient expression assays,
bioluminescent output increased in the first 6 h, and then remained relatively
stable between 6 h and 12 h with an average hourly total flux increase of 6.62 (±
0.10) × 103 p/s. A rapid increase of light production was observed between 12 h
to 26 h with an average increase in total flux of 4.28 (± 0.26) × 104 p/s per hour,
followed by another relatively stable phase between 26 h and 40 h. Following this
stable phase was a short but relatively rapid rise in bioluminescent expression
between 40 h and 48 h, increasing from 8.50 (± 0.59) × 105 p/s to 9.75 (± 0.67) ×
105 p/s. After peaking at approximately 48 h post plating, light production rapidly
decrease, indicating comprising cellular health and cell death. No significant
bioluminescence was observed after ~ 84 h of imaging.
For these cells to be useful as a reporter, the bioluminescent output must be
detectable over a dynamic population range. To determine minimum detectable
cell numbers, T-47D/Lux cells at concentrations ranging from 2.5 × 103 to 2.5 ×
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A

B

Figure 15. Bioluminescent profile of the constitutively bioluminescent
T-47D/Lux cell line.
(A) Ninety-six hour continuous monitoring of approximately 1 × 106
autonomously bioluminescent T-47D/Lux cells (n=3, mean ± standard
error). (B) Correlation between bioluminescent output and overall
population size.
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105 were plated in triplicate in equal volumes of media over a constant surface
area for signal detection. Using a 10 min integration time, approximately 2.5 ×
103 cells could be significantly differentiated from medium background (p < 0.01).
It was also revealed that the bioluminescent flux correlated tightly to the number
of cells present in a population in a linear fashion (R2 > 0.99) (Figure 15B),
suggesting that the bioluminescent output could be used to as an indicator of
population size.
Bioluminescent dynamics upon estrogen-stimulated cell proliferation
The T-47D/Lux cells were subsequently examined for their potential
application in an estrogen screening assay. To determine if the bioluminescent
dynamics could be used to denote estrogen-stimulated cell proliferation, equal
numbers of cells were exposed to varying concentrations of E2. Due to the
inability to maintain long term cellular health in the imaging chamber, continuous
imaging was not attempted. Instead, cells were incubated at optimal growth
condition (5% CO2 at 37°C) with bioluminescence being measured every 24 h
using the IVIS imaging system. Because cells remained intact and attached to
the growing surface during measurements, it was possible to track the
bioluminescent dynamics of the same population throughout the course of
exposure (Figure 16A). While exposure to 0.1 pM E2 was not capable of
increasing bioluminescence significantly compared to unexposed control
throughout the 6-day exposure period (Table 10), a significant change in
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A

17β-estradiol concentration

B

Figure 16. Dose-dependent response of T-47D/Lux reporter cells to
17β-estradiol exposure.
Constitutively bioluminescent T-47D/Lux cells were grown in RPMI-1640
assay medium containing 10% CD-FBS supplemented with various
concentrations of 17β-estradiol (0 (control) to 100 nM) to induce cell
proliferation. (A) Because of the autonomous nature of the lux system,
bioluminescent production from the same cell population could be measured
repeatedly throughout the 6-day period of exposure. (B) Bioluminescent
dynamics also responded to 17β-estradiol treatment in a dose-dependent
manner, exemplified by the bioluminescent measurements 4 days post
exposure (n=3, mean ± standard error).
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Table 10. Bioluminescence produced from T-47D/Lux cells in response to 17βestradiol (E2) exposure.
Hatched grey boxes indicate bioluminescent output similar to unexposed control (p > 0.05 or
fold change < 1.2). Orange boxes indicate significantly different bioluminescence compared
with unexposed control (p < 0.05 and fold change > 1.2).

E2 Treatment vs. Vehicle Control
Time (d)
0
1
3
4
5
6

0.1 pM

1 pM

10 pM

100 pM
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1 nM

10 nM

100nM

bioluminescent production (p < 0.05) was observed 3 days after exposure to
concentrations of E2 as low as 1 pM. It was also shown that E2 stimulated
distinctive bioluminescent dynamics in a time- and dose-dependent manner.
Treatment with 1 pM E2 resulted in a significant change in bioluminescence after
3 days of exposure, but the signal was no longer distinguishable from vehicle
control after 4 days. Higher concentrations of E2 were able to elicit light
production after 3 days of exposure and were significantly distinguishable from
the control for the rest of the exposure period (Table 10). Based on the
bioluminescent measurement after 4 days of exposure, it was determined that
the EC50 for E2 in this assay was approximately 10 pM (Figure 16B).
Development towards an autonomously bioluminescent estrogen reporter
Development of a traditional luxAB bioreporter
A regulatory promoter containing three tandem copies of the ERE (estrogen
responsive element) and the adenovirus E1B minimal TATA box was tested for its
capability to mediate estrogen-inducible bacterial luciferase (LuxAB) expression
(Figure 17A). This promoter was synthesized de novo and cloned into the
previously validated pIRES LuxAB vector to replace the constitutive CMV IE
promoter. This vector (pERE3-TATA LuxAB) was examined in human breast
cancer T-47D cells because they endogenously express both forms of the
estrogen receptor (ERα and ERβ) that are essential for estrogen-mediated gene
expression.
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Transiently transfected T-47D cells were exposed to 10 nM 17β-estradiol (E2)
for various times, then lysed and subjected to the cell-lysed based
bioluminescence assay to determine luciferase activity. Results showed that
expression of the LuxAB proteins was induced by estrogen in a time-dependent
manner (Figure 17B). Luciferase activity was increased by ~ 4.5 (± 0.3)-fold over
untreated control after 6 h of exposure. Maximal induction within the time frame
tested was achieved at 11.3 (± 1.5)-fold after 24 hours of exposure, with peak
luminescent expression of 7.64 (± 0.31) × 104 RLU/mg total protein. Exposure
times longer than 24 h were not attempted because this was the maximal
treatment time employed in the conventional literature.
Having demonstrated the effectiveness of this vector for estrogen-inducible
expression in transient assays, a T-47D cell line stably expressing the pERE3TATA LuxAB vector was selected and examined for responsiveness and
sensitivity to E2. The reporter cells were exposed to E2 concentrations from 5 pM
to 10 nM for 24 hours before proteins were extracted for bioluminescence assays.
Data were reported as fold induction over vehicle controls. As shown in Figure
17C, LuxAB activity was induced by E2 in a dose-responsive manner. While 5 pM
E2 failed to induce LuxAB expression at a significant level (p > 0.05), treatment
with 10 pM E2 increased LuxAB activity significantly (p < 0.05) by ~ 2.00 (± 0.10)fold. Maximal induction was achieved at 10.10 (± 0.57)-fold by stimulation with 10
nM E2.
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A
B

C

Figure 17. 17β-estradiol induced bacterial luciferase (LuxAB) activity.
(A) Schematic representation of the pERE3-TATA LuxAB reporter construct
(ERE: estrogen response element, TATA: adenovirus E1B minimal promoter).
Bacterial luciferase activity was assayed in (B) T-47D cells transiently
transfected with the pERE3-TATA LuxAB reporter vector upon induction with 0
(control) or 10 nM 17β-estradiol (E2) over a 24-hour exposure and (C) in a
stable T-47D reporter cell line expressing the same vector upon 24-hour
induction within a range of E2 concentrations (n=3, mean ± standard error).
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Bioluminescent measurement of ERE-lux reporter cells in response to
estrogen
Following the successful demonstration of estrogen-responsive LuxAB
expression in the pERE3-TATA LuxAB vector, the synthetic ERE3-TATA promoter
was tested for its ability to express the full lux cassette for autonomous
bioluminescent production using the pERE3-TATA Lux vector. While no
background bioluminescence was detected without estrogen induction, treatment
with 1 or 10 nM E2 was not able to induce light production to a detectable level.
To improve expression, the TATA promoter was replaced by the CMV IE minimal
promoter (CMVm), which has been suggested to have a higher basal activity. No
detectable bioluminescence was produced in cells expressing the modified
vector, regardless of estrogen concentrations.
Correlating gene expression and bioluminescent production
The expression of luxC in T-47D cells transiently expressing pERE3-CMVm
Lux was evaluated by qRT-PCR and compared with that of stable bioluminescent
T-47D cells (Table 11). Two bioluminescent T-47D cell lines stably expressing
pCMV Lux, including one with a low level of bioluminescence (~ 1.66-fold over
background) and the other with a higher level of light production (~ 90.77-fold
over background), were chosen for comparison. While luxC transcription was ~
52.5% of β-actin transcription in the stable cell line with high levels of constitutive
bioluminescence expression, it was only expressed at ~ 6.0% relatively to β-actin
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Table 11. Comparison of luxC expression level determined by qRT-PCR in various
lux-expressing T-47D cells.
luxC expression level
relative to β-actin (%)

Cell type

Bioluminescence
relative to background
(fold change)

T-47D cells transiently expressing pERE3-CMVm Lux
24-hour treatment with
0 nM E2

3.15 (2.80 - 3.56)

not significant

24-hour treatment with
1 nM E2

6.27 (4.46 - 8.82)

not significant

T-47D cells stably expressing pCMV Lux
Low bioluminescent
expression cell line

6.04 (4.22 - 8.64)

1.66 ( ± 0.18)

High bioluminescent
expression cell line

52.50 (39.58 - 69.64)

90.77 ( ± 5.79)
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transcription in the low bioluminescent expression cells. In the reporter cells
expressing pERE3-CMVm Lux, luxC transcription relative to β-actin transcription
increased from ~ 3.2% to ~ 6.3% following a 24-hour exposure to 1 nM E2.
Demonstration of the lux system as a fully autonomous Tet-On reporter
The functionality of the lux cassette as a fully autonomous, real-time reporter
for target-regulated gene expression was investigated using a well-characterized
Tet-On mammalian expression system. HEK293 Tet-On cells constitutively
expressing the Tet-On transactivator were transfected with a tetracycline
response element regulated lux reporter construct (pTet Lux) and the dynamics
of doxycycline-induced bioluminescent response was determined over a 19 h
imaging course (Figure 18). Without doxycycline induction, the Tet-lux reporter
cells displayed a background luminescence of ~ 2.57 × 104 p/s, which decreased
gradually over time. Exposure to 100 ng doxycycline/ml induced bioluminescent
production that could be differentiated from un-induced control as early as 2.5
hours post treatment (p < 0.05). From this point on, light production continued to
increase rapidly with increasing treatment time, reaching a total flux of ~ 1.33 ×
107 p/s after 19 h of exposure.
The expression of the lux genes was also investigated in parallel to determine
transcriptional activation following doxycycline induction. Quantitative RT-PCR
analysis was performed to measure the expression of the luxC, luxB, and frp
genes 19 hours post treatment with 100 ng doxycycline/ml. Compared to
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Figure 18. Continuous near-real time monitoring of the bioluminescent
response to doxycycline treatment of the HEK293 Tet-lux reporter cells.
HEK293 Tet-on cells transiently expressing the pTet Lux reporter construct
were treated with 0 (control) or 100 ng doxycycline/ml. Treatment with 100 ng
doxycycline/ml increased bioluminescent output as early as 2.5 hours post
induction and approached a maximal bioluminescent output of ~ 1.33 x 107
p/s over the 19-hour exposure period (n=2).
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untreated control, the luxC and luxB genes were up-regulated by ~ 8.6 (range:
7.1 - 10.4)-fold and ~ 8.2 (range: 6.3 - 10.6)-fold, respectively. The frp gene was
also up-regulated upon doxycycline treatment, but displayed a slightly higher fold
change of ~ 13.2 (range: 10.1 - 17.3) compared to control (Figure 19).

Discussion
The most distinct advantage of using a lux-based human cell bioreporter is its
ability to indicate human-relevant effects in a living system and in an autonomous
fashion without the requirement of cell destruction or exogenous substrate
addition. Thus far, only proof-of-principle demonstrations of lux expression in
mammalian cells have been provided (Close, Patterson et al. 2010; Close, Hahn
et al. 2011), and its application remains limited. The findings in this study
represent the use of bioluminescence produced autonomously from human cell
lines to directly detect the bioavailability of targets of interest, and facilitate future
development of the lux system towards high throughput, real time screening
systems.
One popular application of bioluminescent reporters is to use the
bioluminescent signal to monitor cellular population dynamics. This is made
possible because of the quantitative relationship between signal intensity and the
number of cells present in a population (Contag and Ross 2002). For instance,
cells constitutively expressing firefly luciferase have been widely applied for in
vivo assessment of tumor growth and response to cancer therapies
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Figure 19. Regulation of lux gene expression in response to
doxycycline induction in the Tet-lux reporter cells.
Gene expression was analyzed by qRT-PCR on HEK293 Tet-On cells
transiently expressing the pTet Lux reporter vector were treated with 0 (Dox) or 100 (+ Dox) ng doxycycline/ml for 19 hours (n=6 (2 biological
replicates each with 3 technical replicates), mean ± standard error).
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(Prescher and Contag 2010). However, the firefly luciferase system requires a
substrate to be added exogenously prior to data acquisition. To provide a proofof-principle demonstration of lux-tagged human cell lines for non-invasive
monitoring of population dynamics, a constitutively bioluminescent cell line, T47D/Lux, was developed and evaluated for its potential application as an in vitro
bioluminescent cell proliferation assay for estrogenic compounds.
Human breast cancer T-47D cells are estrogen sensitive, meaning that their
proliferative behavior is regulated by estrogen (Soto, Murai et al. 1986). Scientific
investigations in the past two decades have accumulated evidence suggesting
that estrogen regulates cell proliferation by negating the proliferative inhibition
exerted by plasma-borne albumins and their interaction with membrane-bound
estrogen receptors (Sonnenschein, Soto et al. 1996; Powell, Soto et al. 2001;
Powell, Soto et al. 2003). Based on these premises, the E-SCREEN assay was
developed 27 years ago for measuring the physiological signature of the action of
estrogen (i.e., induction of cell proliferation) and is still widely used for
identification

of

chemicals

with

potential

estrogenic

activities

(Soto,

Sonnenschein et al. 1995). This assay compares the cell yield following 5-day to
6-day incubation in the presence or absence of estrogen. The original method of
quantifying cell numbers involved direct nuclei counting, but a higher throughput
and less laborious colorimetric MTT assay has been widely adopted as the
endpoint measurement of viable cell counts. Regardless of the method used, cell
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lysis is required prior to data acquisition, which therefore provides only single
time point snapshots.
However, it is demonstrated in this study that by using the autonomous
bioluminescence emitted from T-47D/Lux cells as the endpoint of measurement,
the same cell population can be monitored repeatedly throughout the course of
exposure; therefore, cell proliferation can be captured progressively at any time
point of interest. Results show that the bioluminescent signal emitted from these
modified T-47D cells responds to estrogen in a dose-dependent manner,
exemplified by a typical sigmoidal curve that is similarly obtained using other
endpoint measurements (Figure 16B) (Soto, Sonnenschein et al. 1995). 17βestradiol

concentrations

to

induce

maximal

and

half-maximal

(EC50)

bioluminescence in our assay are approximately 0.1 nM and 10 pM, respectively.
These values are comparable to that measured in the traditional E-SCREEN
method (EC50 = 7 - 12 pM using MCF-7 cells) (Soto, Maffini et al. 2006). The
minor discrepancies between our results and those reported in other studies are
most likely due to logistical factors such as differences between cell line clones
and culture conditions (Zacharewski 1997). However, in general, using
bioluminescent output as an indicator for cell proliferation, estrogen can be
detected in the picomolar range.
It is clear that for these bioluminescent cells to be widely applied as a
screening method for estrogenic substances, detailed validation and comparison

141

with current bioassays will be required. However, during this proof-of-principle
demonstration, similar results to those obtained using the traditionally methods
following estrogen treatment were acquired. Additionally, this method offers the
advantage that data acquisition can be performed in a fully automated fashion
since the need for sample destruction or substrate addition is eliminated, making
it an ideal candidate for high-throughput analysis. It also permits the tracking of
dynamic effects upon the same population over time, which is not feasible using
traditional cell lysis-requiring methods. As an example, treatment with low levels
of estrogen (0.1 pM) only produced intermittently significant signal over the 6-day
course of exposure (Table 10). These types of dynamics would likely be
overlooked using the traditional single time point approach. Moreover, these
autonomously bioluminescent cells have the potential to be implemented into an
in vivo tumor model for basic and preclinical research, as they permit noninvasive interrogation of cellular events in living animals.
Another important application of bioluminescent reporters is for the detection
of specific target compounds via monitoring target-regulated expression of their
reporter gene. Under this strategy, the expression of the reporter gene is linked
to a promoter that is responsive to the target analyte. In this study, it was further
investigated whether or not lux expression could be regulated by an estrogenresponsive promoter for estrogenic compound detection. Because the promoter
architectures for optimized estrogen regulation are not well studied, a synthetic
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promoter was first evaluated using the LuxAB reporter system before being
applied for full lux cassette expression. This promoter, consisting of three tandem
copies of EREs spaced 4 bp apart and a TATA promoter located 8 bp
downstream of the EREs, was shown to be capable of functionally regulating
LuxAB expression in response to a dynamic range of E2 concentrations (Figure
17C). While a 24-hour exposure to 10 pM E2 induced LuxAB activity significantly,
the most rapid increase was observed at E2 concentrations between 100 pM and
10 nM, with a maximal induction of ~ 10-fold over untreated control. Although this
maximal fold change is similar to a previously published study using firefly
luciferase as a reporter in T-47D cells, Wilson et al. have previously reported a
lower detectable concentration at 0.1 pM, with maximal induction occurring at
100 pM (Wilson, Bobseine et al. 2004). The variation in sensitivity in our system
is not unexpected due in part to the relatively low quantum yield of the bacterial
luciferase luminescent reaction compared to that of the firefly luciferase reaction.
Other factors, including variations in ERE substitution mutations and flanking
sequences, the relative position of the TATA promoter to the EREs, and the
genetic content linking the promoter and the protein coding region, can also
contribute to the disparity in reporter gene expression (Klinge 2001).
Despite the effective regulation of LuxAB expression, this promoter and its
CMVm variant were not capable of expressing the full lux cassette at the level
required to produce detectable bioluminescence in cell culture, regardless of
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estrogen induction. However, qRT-PCR analysis did show that expression of the
luxC gene increased by ~ 1.99 (1.38 - 2.85)-fold after 24-hour exposure to 1 nM
E2, suggesting that the promoter activity did up-regulate gene expression in an
estrogen-responsive fashion. Therefore, the discrepancy in the detectability of
these endpoint measurements (i.e., enzyme activity and bioluminescent flux) is
likely caused by variations in the sensitivity of the detection scheme. To estimate
the threshold of lux expression for detectable autonomous bioluminescence, we
selected two stable bioluminescent T-47D cell lines - one with a minimum level of
bioluminescence (~1.66 fold over background) and the other displaying a much
greater level of light production (~ 90.77 fold over background) - and compared
the transcript level of the luxC gene in these two cell lines to that in cells
expressing the pERE3-CMVm Lux reporter construct. As expected, higher light
output was associated with a significantly higher level of gene expression,
expressing luxC at ~ 52.5% of β-actin gene expression compared to ~ 6.0% in
the low expression bioluminescent cells (Table 11). It was also confirmed that the
ERE3-minimal promoter was only capable of expressing luxC at ~ 3.2% without
and ~ 6.3% following estrogen induction relative to β-actin gene expression.
Therefore, the most probable explanation for the inconsistency of detectability
between LuxAB activity and light output measurements is that autonomously
bioluminescent detection requires a relatively high level of expression of all six
lux genes.
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Due in part to the poor performance of estrogen-regulated bioluminescent
expression, an alternative regulation system was utilized to assess the potential
of lux-based bioluminescence being used for detection of targets of interest. By
using a tetracycline-responsive promoter that has been well characterized and
extensively optimized for tight regulation and high levels of expression in
mammalian cells, the ability of lux expression to function as an autonomously
bioluminescent reporter for doxycycline detection has been demonstrated in this
study. Unlike other bioluminescent reporters that require substrate addition (and
in some cases cell lysis) to produce a detectable signal (therefore providing only
single time point measurements), the lux reporter system allows for continuous
monitoring of the same sample without cell destruction or exogenous substrate
addition.

This

allowed

bioluminescent

production

from

cells

transiently

expressing the pTet Lux vector in response to doxycycline to be recorded in a
continuous, near real-time manner. Without doxycycline treatment, these reporter
cells displayed a low level of bioluminescent production (~ 2.6 × 104 p/s), which
decreased gradually over time, possibly due to compromised cellular metabolism
caused by nutrient depletion from the medium and the inability to regulate the
CO2 level and humidity in the imaging chamber. In contrast, treatment with 100
ng doxycycline/ml resulted in increasing light production throughout the course of
treatment. The minimal time to induce significantly different light production was
determined to be ~ 2.5 h for the 100 ng doxycycline/ml treatment. It was also
demonstrated that an approximate 800-fold change in light production could be
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achieved within 19 hours post treatment under the same treatment level (Figure
18). Ultimately, under this expression strategy, the maximal light production
induced by doxycycline was greater than that from equal numbers of cells
expressing identical genes under the control of a constitutive CMV IE promoter
(Chapter II), which was in agreement with previously published studies (Qin,
Zhang et al. 2010).
A direct comparison of these values to previously published literature using
similarly constructed firefly luciferase reporters would be desirable but is not
possible for several reasons. First, most of the published research normally
reports fold induction at sporadic time points but not minimal induction time,
which is probably prohibited by the extensive amount of laboratory work and
sample size that would be required for providing this type of information in the
firefly luciferase system. Second, luciferase activity is mostly reported in arbitrary
relative light units instead of direct photon counts used in our study, thus the
varying sensitivity between detection methods would affect the direct comparison
of fold changes. Third, it is known that the activity of the tetracycline-responsive
promoter varies in different cell types (Gossen, Freundlieb et al. 1995). Therefore,
a relevant comparison would require that the same cell type, transfection method,
promoter, and inducing concentration all be maintained across two studies.
Therefore, in order to provide objective interpretations, the lux-based
bioluminescence data was compared with gene expression data obtained from
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the same cells. It was determined that, while transcription of the lux genes
increased by approximately 8-fold after a 19-hour exposure to doxycycline at a
concentration of 100 ng/ml (Figure 19), the corresponding increase in light
production was ~ 800-fold under these same conditions (Figure 18). These
results suggest that a relatively small up-regulation in gene expression can
significantly amplify the bioluminescent output. Because of the relatively low
signal intensity of the lux system compared to the firefly luciferase system when
both are expressed constitutively (Close, Hahn et al. 2011), there have been
concerns over the detectability of the lux system under inducible conditions.
However, our results demonstrated that a sufficiently high signal-to-noise ratio
could be achieved using the Tet-On regulation system. Most importantly,
however, these results suggest that real-time, continuous tracking of gene
expression regulated by the target of interest (doxycycline in this case) makes
lux-based bioreporters ideal candidates for detecting the on-set and dynamics of
gene expression.
Unlike the synthetic tetracycline-responsive promoter that has been well
characterized and extensively optimized for tight regulation and high levels of
expression in mammalian cells (Gossen, Freundlieb et al. 1995; AghaMohammadi, O'Malley et al. 2004; Loew, Heinz et al. 2010), promoter
architectures for optimized estrogen regulation are poorly studied. The literature
suggests that the EREs are relatively weak regulatory elements, with most
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natural EREs only inducing reporter gene activity by less than 10-fold (reviewed
by Klinge (2001)). In contrast, the Tet-On system can induce firefly luciferase
activity by several thousand fold (Gossen, Freundlieb et al. 1995), which explains
why the Tet-lux reporter has enjoyed commercial success. This discrepancy is
also affirmed by our data which indicates that doxycycline and estrogen induced
luxC transcription by ~ 8- and ~ 2-fold, respectively.
For these reasons, it becomes clear that extensive optimizations of the
current estrogen-responsive promoter to improve transcriptional activation will be
an important route for development towards a functional and autonomous luxbased estrogen reporter system. A potential route for optimization could be to
modify the flanking regions of the EREs to contain AT-rich sequences since they
have been found to improve estrogen receptor binding and transcriptional
activation (Klinge, Jernigan et al. 2001). In addition, the copy numbers of ERE
and the distance between them have also been shown to mediate synergistic
activation (Tyulmenkov, Jernigan et al. 2000) and could be modified accordingly.
And finally, because estrogen receptors interact with both general transcriptional
factors and other co-regulators (Klinge 2000), the spacer between the EREs and
the minimal promoter could be modified to alter the steric hindrance resulting
from transcriptional initiation complex formation at the TATA box. This represents
a particularly attractive first step for optimization because it has resulted in up to
a 100-fold induction of firefly luciferase activity when using a promoter containing
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three tandem ERE repeats and a TATA minimal promoter with an ~ 30 bp linker
(Legler, van den Brink et al. 1999).
Optimizations can also be made to the configuration of the lux cassette.
There have been reports suggesting that splitting the lux cassette into two small
transcription units with one being constitutively expressed and the other under
regulation can result in improved reporter performance compared to regulating all
lux genes at once in E. coli (Yagur-Kroll and Belkin 2011). Mathematical
modeling also predicts that induction of the luxC and luxE genes would provide
the most rapid control over bioluminescent production (Welham and Stekel 2009).
While these predictions remain to be validated in the mammalian cellular
background, the Tet-lux reporter system demonstrated in this study will be an
ideal candidate for these investigations.
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CHAPTER V
Summary and Conclusions
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Bioluminescent sensing is an emerging biomedical surveillance strategy that
uses external cameras to detect in vivo light generated in small animal models of
human physiology or in vitro light generated in tissue culture or tissue scaffold
mimics of human anatomy. At the core of this technology are cells expressing
light emitting reporter proteins that reveal the activation dynamics of cellular and
molecular functions. As the most recent addition to the bioluminescent reporter
protein family for mammalian expression, the lux system is the only reporter that
permits fully autonomous signal production without the requirement of exogenous
excitation or substrate addition, making it an ideal candidate for continuous realtime monitoring of cellular events in cell culture and living animals. However, the
signal intensity of the previously characterized lux expression system is much
lower than that of other bioluminescent reporter systems (Close, Hahn et al.
2011), and thus provides a major limitation preventing its more widespread
adoption. In addition, the previously validated lux expression strategy requires
two vectors for autonomously bioluminescent production (Patterson, Dionisi et al.
2005; Close, Patterson et al. 2010), which complicates the process of generating
additional bioluminescent cell lines. For these reasons, the application of the
mammalian-adapted lux system remains limited. Overall, this dissertation has
aimed to 1) develop a more simplistic and efficient format for expression of the
lux cassette in human cell lines, 2) identify the constraints limiting bioluminescent
expression in the previously characterized bioluminescent cells and develop a
strategy to improve light output, and 3) validate the capability of lux-expressing
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human cell lines for monitoring population dynamics and detecting the
bioavailability of targets of interest. The following conclusions have been drawn
from this investigation in regards to the initial hypotheses:
Hypothesis 1: Through the use of viral 2A peptides as linker regions, it
will be possible to simultaneously express up to six genes (the
luxCDABEfrp gene cassette) under the regulation of a single promoter for
autonomous bioluminescent production in human cell lines.
This investigation has demonstrated, for the first time, the capability of viral
2A peptides to mediate efficient expression of up to six genes. 2A-mediated
polycistronic expression of the codon-optimized lux cassette has been shown to
be capable of producing constitutive bioluminescence under the regulation of a
single promoter in the human cellular background. While the previously
characterized two plasmid system is thus far limited to HEK293 cells, due likely
to the complicated process of generating cell lines stably expressing two
expression vectors, the 2A-based single vector polycistronic expression format
has been validated in a panel of human cell lines and reduces both the time and
effort required to develop additional bioluminescent cell lines. The coupled
transcription and translation of the lux genes, conferred by the use of a single
promoter and 2A elements capable of mediating highly efficient stoichiometric
protein expression, has been shown to improve bioluminescent production over
the IRES-based two plasmid expression system.
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Hypothesis 2: The human cellular background is capable of supplying
sufficient endogenous substrates for high level lux-based bioluminescent
production. Therefore, it will be possible to improve bioluminescent
expression through increased gene integration.
It has been shown that lux gene copy number is a major limiting factor for
bioluminescent production

in the previously characterized, un-optimized

bioluminescent HEK293 cells. While additional copies of the luciferase genes
(luxAB) or the substrate processing genes (luxCDEfrp) increased bioluminescent
flux to a certain extent, the largest output gain (~ 80-fold) was achieved following
introduction of the full lux cassette assembled into a single vector. These results
support the initial hypothesis that the availability of endogenous substrates in the
human cellular background is not a limiting factor for light production in the unoptimized bioluminescent cells.
The results obtained in this investigation have also lead to the development of
a two-step transfection strategy for high level bioluminescent expression. By preestablishing a stable cell line expressing a partial lux sequence (i.e., luxAB), it
was possible to synergistically improve the expression of the latterly introduced
lux cassette. Both the data presented in this study, and in the literature, implies
that homology-mediated gene integration may play a role in this improved
expression, however, detailed mechanisms still remain to be assessed
experimentally in order to identify the exact integration locus.
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An optimized HEK293 cell line with enhanced bioluminescent production has
been constructed using the two-step transfection strategy. The enhanced signal
intensity allows bioluminescent detection from a smaller population size (~ 15
fold lower) in cell culture compared to their un-optimized counterparts. Although
their signal intensity is still not as strong as other conventional bioluminescent
reporters, the optimized cells offer an improved dynamic detection range, which
will certainly provide a substrate-free alternative for desired applications. In
addition, due to the improved photonic flux, the enhanced bioluminescent cells
have been shown to be compatible with multiple types of detection, including
highly sensitive CCD camera-based imaging and the relatively less sensitive, but
lower cost and more commonly used, photomultiplier tube (PMT)-based plate
reading. The adoption of the autonomously bioluminescent lux-expressing cells
for use under these conditions has the capacity to facilitate both high throughout
and on-line monitoring applications.
Hypothesis 3: Bioluminescent production dynamics in estrogenresponsive human breast carcinoma T-47D cells can be used as an
indicator for estrogen-regulated cell proliferation.
It has been shown here that bioluminescence constitutively emitted from luxexpressing cells can be utilized for monitoring population dynamics in a
continuous and non-invasive manner. A constitutively bioluminescent T-47D/Lux
cell line has been developed using the polycistronic lux expression vector and
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utilized in an estrogen screening assay. Results obtained in this investigation
show that the estrogen-induced, dose-dependent cell proliferative response is
comparable to that obtained using traditional methods, and can be captured by
using the autonomous bioluminescence produced from living cells as an endpoint
measurement (Soto, Sonnenschein et al. 1995; Soto, Maffini et al. 2006). It has
also been shown that estrogen can be detected in the picomolar range using this
method. While detailed validation and comparison with current bioassays will be
required before these bioluminescent cells can be widely applied as a screening
method for estrogenic compounds, this method has the potential to be
implemented as a fully automated, high throughput analysis tool since the need
for sample destruction or substrate addition is alleviated. In addition, this system
also permits the tracking of dynamic effects upon the same population over time,
which is not feasible using traditional cell lysis-requiring methods.
Hypothesis 4: By simultaneously regulating the expression of the lux
genes assembled in a polycistronic single vector, it will be possible to
construct a bioluminescent reporter capable of responding to target
analytes autonomously and in a near real-time manner.
The ability of lux expression to function as an autonomous bioluminescent
reporter for the detection of targets of interest has been demonstrated in this
investigation. Although the lux system is not currently amenable for
autonomously bioluminescent detection of estrogenic compounds due to the
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relatively weak transcriptional activation elicited by the estrogen response
elements, it has been shown that regulation of the lux genes under the control of
a single tetracycline-responsive promoter is capable of governing bioluminescent
production in response to administration of the inducing compound doxycycline.
The 2A-mediated polycistronic assembly of all six lux genes provides a simplistic
means for maintaining low background bioluminescent expression and tightly
regulated, increased bioluminescent production upon induction. It has further
been shown that lux-based bioluminescent output is highly sensitive, with a
relatively small up-regulation in gene expression yielding a sufficiently high
signal-to-noise ratio expression for facile detection. Unlike other substraterequiring bioluminescent

reporters

that provide

only single

time point

measurements, the autonomous lux reporter system permits doxycyclineregulated bioluminescent production from the same cell population to be
recorded in a continuous, near real-time fashion, therefore making it an ideal
candidate for detecting the on-set and dynamics of target-regulated gene
expression.
Since the estrogen-responsive promoter has not yet enjoyed the same
extensive optimization as the synthetic tetracycline-responsive promoter has for
high level of expression in mammalian cells, it is suggested that future work be
focused on modifying the estrogen-responsive promoter architecture with the aim
of enhancing transcriptional activation as an important route for developing an
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autonomously bioluminescent estrogen bioreporter.
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